WO1997024616A1 - Procede de determination du taux de viabilite de cellules - Google Patents
Procede de determination du taux de viabilite de cellules Download PDFInfo
- Publication number
- WO1997024616A1 WO1997024616A1 PCT/JP1996/003842 JP9603842W WO9724616A1 WO 1997024616 A1 WO1997024616 A1 WO 1997024616A1 JP 9603842 W JP9603842 W JP 9603842W WO 9724616 A1 WO9724616 A1 WO 9724616A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acid
- cells
- intensity
- cell
- cell membrane
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 82
- 210000004027 cell Anatomy 0.000 claims abstract description 248
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 110
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 110
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 102
- 210000000170 cell membrane Anatomy 0.000 claims abstract description 86
- 238000005259 measurement Methods 0.000 claims description 117
- 239000007850 fluorescent dye Substances 0.000 claims description 81
- 239000003814 drug Substances 0.000 claims description 51
- 230000003833 cell viability Effects 0.000 claims description 46
- 229940079593 drug Drugs 0.000 claims description 45
- 239000003795 chemical substances by application Substances 0.000 claims description 28
- 239000002736 nonionic surfactant Substances 0.000 claims description 13
- -1 cyanine nucleic acid Chemical class 0.000 claims description 11
- 239000004094 surface-active agent Substances 0.000 claims description 9
- GTSMOYLSFUBTMV-UHFFFAOYSA-N ethidium homodimer Chemical compound [H+].[H+].[Cl-].[Cl-].[Cl-].[Cl-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2C(C)=[N+]1CCCNCCNCCC[N+](C1=CC(N)=CC=C1C1=CC=C(N)C=C11)=C1C1=CC=CC=C1 GTSMOYLSFUBTMV-UHFFFAOYSA-N 0.000 claims description 5
- 238000000691 measurement method Methods 0.000 claims description 4
- 230000003213 activating effect Effects 0.000 claims 1
- 238000010186 staining Methods 0.000 abstract description 13
- 238000012360 testing method Methods 0.000 abstract description 5
- 230000004083 survival effect Effects 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 88
- 239000000243 solution Substances 0.000 description 17
- 231100000135 cytotoxicity Toxicity 0.000 description 15
- 230000003013 cytotoxicity Effects 0.000 description 15
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 14
- 238000003756 stirring Methods 0.000 description 11
- 239000000126 substance Substances 0.000 description 10
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 8
- 230000005284 excitation Effects 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 7
- 239000013504 Triton X-100 Substances 0.000 description 6
- 229920004890 Triton X-100 Polymers 0.000 description 6
- 238000011088 calibration curve Methods 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 230000001988 toxicity Effects 0.000 description 6
- 231100000419 toxicity Toxicity 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- QBKMWMZYHZILHF-UHFFFAOYSA-L Po-Pro-1 Chemical compound [I-].[I-].O1C2=CC=CC=C2[N+](C)=C1C=C1C=CN(CCC[N+](C)(C)C)C=C1 QBKMWMZYHZILHF-UHFFFAOYSA-L 0.000 description 4
- 239000003905 agrochemical Substances 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000006911 enzymatic reaction Methods 0.000 description 4
- 229960004857 mitomycin Drugs 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- IDOQDZANRZQBTP-UHFFFAOYSA-N 2-[2-(2,4,4-trimethylpentan-2-yl)phenoxy]ethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=CC=C1OCCO IDOQDZANRZQBTP-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920004929 Triton X-114 Polymers 0.000 description 3
- 230000001464 adherent effect Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 108090000371 Esterases Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 231100000002 MTT assay Toxicity 0.000 description 2
- 238000000134 MTT assay Methods 0.000 description 2
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000003068 molecular probe Substances 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- 229920002113 octoxynol Polymers 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000003359 percent control normalization Methods 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 238000000053 physical method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 108700004121 sarkosyl Proteins 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 description 1
- IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 1
- GUQQBLRVXOUDTN-XOHPMCGNSA-N 3-[dimethyl-[3-[[(4r)-4-[(3r,5s,7r,8r,9s,10s,12s,13r,14s,17r)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 GUQQBLRVXOUDTN-XOHPMCGNSA-N 0.000 description 1
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
- 201000008808 Fibrosarcoma Diseases 0.000 description 1
- 101000573199 Homo sapiens Protein PML Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000031671 Large B-Cell Diffuse Lymphoma Diseases 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- CZQJZBNARVNSLQ-UHFFFAOYSA-L Po-Pro-3 Chemical compound [I-].[I-].O1C2=CC=CC=C2[N+](C)=C1C=CC=C1C=CN(CCC[N+](C)(C)C)C=C1 CZQJZBNARVNSLQ-UHFFFAOYSA-L 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
- DPXHITFUCHFTKR-UHFFFAOYSA-L To-Pro-1 Chemical compound [I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=C1C2=CC=CC=C2N(CCC[N+](C)(C)C)C=C1 DPXHITFUCHFTKR-UHFFFAOYSA-L 0.000 description 1
- QHNORJFCVHUPNH-UHFFFAOYSA-L To-Pro-3 Chemical compound [I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=CC=C1C2=CC=CC=C2N(CCC[N+](C)(C)C)C=C1 QHNORJFCVHUPNH-UHFFFAOYSA-L 0.000 description 1
- MZZINWWGSYUHGU-UHFFFAOYSA-J ToTo-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3S2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2S1 MZZINWWGSYUHGU-UHFFFAOYSA-J 0.000 description 1
- 229920004894 Triton X-305 Polymers 0.000 description 1
- 229920004896 Triton X-405 Polymers 0.000 description 1
- 235000005811 Viola adunca Nutrition 0.000 description 1
- 240000009038 Viola odorata Species 0.000 description 1
- 235000013487 Viola odorata Nutrition 0.000 description 1
- 235000002254 Viola papilionacea Nutrition 0.000 description 1
- JSBNEYNPYQFYNM-UHFFFAOYSA-J YoYo-3 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=CC=C2N(C3=CC=CC=C3O2)C)=CC=[N+]1CCC(=[N+](C)C)CCCC(=[N+](C)C)CC[N+](C1=CC=CC=C11)=CC=C1C=CC=C1N(C)C2=CC=CC=C2O1 JSBNEYNPYQFYNM-UHFFFAOYSA-J 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000980 acid dye Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000010256 biochemical assay Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- GLNADSQYFUSGOU-UHFFFAOYSA-J chembl1640 Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(N=NC3=CC=C(C=C3C)C=3C=C(C(=CC=3)N=NC=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-UHFFFAOYSA-J 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000000710 homodimer Substances 0.000 description 1
- 102000054896 human PML Human genes 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- YFVGRULMIQXYNE-UHFFFAOYSA-M lithium;dodecyl sulfate Chemical compound [Li+].CCCCCCCCCCCCOS([O-])(=O)=O YFVGRULMIQXYNE-UHFFFAOYSA-M 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000000968 medical method and process Methods 0.000 description 1
- 230000005499 meniscus Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229940051841 polyoxyethylene ether Drugs 0.000 description 1
- 229920000056 polyoxyethylene ether Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 201000006845 reticulosarcoma Diseases 0.000 description 1
- 208000029922 reticulum cell sarcoma Diseases 0.000 description 1
- 229930192014 saikosaponin Natural products 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- XJCQPMRCZSJDPA-UHFFFAOYSA-L trimethyl-[3-[4-[(e)-(3-methyl-1,3-benzothiazol-2-ylidene)methyl]pyridin-1-ium-1-yl]propyl]azanium;diiodide Chemical compound [I-].[I-].S1C2=CC=CC=C2N(C)\C1=C\C1=CC=[N+](CCC[N+](C)(C)C)C=C1 XJCQPMRCZSJDPA-UHFFFAOYSA-L 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000003026 viability measurement method Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/06—Quantitative determination
Definitions
- the present invention provides a simple and rapid method for treating the number of surviving cells and the Z or cell viability of a multi-sample by subjecting the cells to a treatment with a nucleic acid fluorescent stain that stains only dead cells and a treatment to damage the cell membrane. It provides a method for measurement and is used in the fields of research and development of pharmaceuticals, agricultural chemicals, cosmetics, foods, etc., and in the fields of medicine, pharmacy, biological research, and clinical testing and diagnostics, etc. Available. Background art
- the safety and efficacy of pharmaceuticals, pesticides, cosmetics, foods, etc. are often evaluated by their cytotoxicity, and the number of viable cells is often measured as an indicator of this cytotoxicity.
- the methods for detecting and quantifying the number of viable cells or cell viability are as follows: 1) Trypan blue staining method, 2) MTT assay method (Journ alof Immunological Medical Methods, 65, 55-63, 1983) 3Method described in US Pat. No. 5,314,805, 4Molecular Medicine, Vol. 32, pp. 1340-1342, 1995, 5US Patent Publication No. 5,534
- the method described in c 1 which proposes the method described in No.
- 416 is to measure the number of cells stained with the tribble dye, which stains only dead cells blue, within the visual field of the microscope.
- MTT is used as a substrate for mitochondrial dehydrogenase in cells, and the amount of blue-violet formazan resulting from the enzymatic reaction is quantified using an absorptiometer.
- two types of fluorescent substances Rosin AM and ethidium homodimer are allowed to act on the same sample, and the fluorescence emitted from living cells and the fluorescence emitted from dead cells are measured simultaneously. This is a method for measuring the number of viable cells.
- Calcine AM is a substance that usually emits little fluorescence, but is broken down into calcine by the action of esterase in living cells, and emits strong fluorescence.
- Etididium homodimer is a fluorescent nucleic acid stain that has the property of passing only through the damaged cell membrane.It specifically penetrates only dead cells and binds to nucleic acids, and emits fluorescence about 40 times that of normal. Emits.
- the intensity of the fluorescence emitted from the test sample treated with providide iodide, which stains only the DNA of dead cells, and the effect of Hoechst 332,588, which stains DNA of dead cells and live cells, are used.
- This is a method of measuring the intensity of the fluorescence emitted from the measurement sample and comparing the two intensities to measure the cell viability.
- the method of 5 is a cyanine-based nucleic acid fluorescent stain described in US Pat. No. 5,436,134, which stains DNA of both live cells and dead cells.
- This method measures the cell viability by measuring the intensity of the fluorescent light emitted from the measurement sample that has been acted on (they are collectively called Dye II) and comparing the two intensities. .
- the methods (1) and (2) are difficult to distinguish between staining with the dye Tripan Blue and difficult to measure without the naked eye, so the measurement is extremely time-consuming. In principle, it depends on the enzyme reaction, so the measurement temperature, the measured pH, the enzyme reaction time, the difference in the enzyme activity depending on the cell type, etc. Susceptible. In addition, the method (2) requires a centrifugal separation operation and an operation to dissolve the poorly soluble formazan resulting from the enzyme reaction. In method (3), (1) serum-derived esterase in cell culture solution decomposes calcinein AM, so it is necessary to remove serum by washing cells several times, but dead cells are easily removed by washing. However, accurate measurement cannot be performed unless the system uses a serum-free cell culture solution.
- the inventor of the present invention has been able to (1) easily and quickly measure the number of viable cells accurately in many sample samples, and (2) can measure a sample in which serum is present in a cell culture medium. Yes, (3) No complicated operations such as cell washing, cell centrifugation, and dye lysis are required for the measurement sample. (4) Measurement results differ depending on measurement temperature, measurement PH, reagent reaction time, and cell type.
- the present invention was completed as a result of various studies to provide a method for measuring the number of viable cells that satisfies conditions such as being less susceptible to such effects as the above.
- the present invention provides (1) the intensity of fluorescence emitted from a measurement sample to which a nucleic acid fluorescent stain that stains only dead cells has been applied, the treatment of the nucleic acid fluorescent stain, and the treatment of damaging the cell membrane. And the intensity of fluorescence emitted by the measured sample, and comparing the two intensities.
- the method for measuring cell viability and (2) the intensity of fluorescence emitted from a measurement sample to which a nucleic acid fluorescent dye that stains only dead cells is applied, and the measurement sample to which the dye and an agent that damages the cell membrane are applied.
- Fluorescent nucleic acid stains that measure only the number of viable cells and Z or cell viability by measuring the intensity of emitted fluorescence and comparing the two intensities, and agents that damage cell membranes And a kit for measuring the number of viable cells and Z or cell viability. More specifically, the present invention provides
- the intensity of the fluorescence emitted from the measurement sample to which the nucleic acid fluorescent staining agent that stains only dead cells is applied, and the measurement sample subjected to the treatment with the nucleic acid fluorescent staining agent and the treatment to damage the cell membrane are emitted.
- a method for measuring the number of viable cells and / or cell viability comprising measuring the intensity of fluorescence and comparing the two intensities;
- nucleic acid fluorescent dye that stains only dead cells is allowed to act on the measurement sample, and the intensity of the resulting fluorescence is measured. ( â ) Then, a treatment to damage the cell membrane of this sample is performed. (3).
- (0) A nucleic acid fluorescent dye that stains only dead cells is allowed to act on the 0 measurement sample to measure the intensity of the fluorescence enhanced by killing the cells. Measuring the intensity of the fluorescence emitted from the sample, and (ii) subjecting another measurement sample to a treatment with the nucleic acid fluorescent dye and damaging the cell membrane, and measuring the intensity of the fluorescence emitted from the sample. [1] Measurement method described;
- nucleic acid fluorescent stain is a cationic nucleic acid fluorescent stain
- the intensity of the fluorescence emitted by the measurement sample treated with the nucleic acid fluorescent stain that stains only dead cells and the intensity of the fluorescence emitted by the measurement sample treated with the stain and the agent that damages the cell membrane
- Viable cells composed of a nucleic acid fluorescent stain that stains only dead cells and an agent that damages the cell membrane to measure the number of viable cells and Z or cell viability by measuring each and comparing the two intensities Provide kits for measuring number and Z or cell viability.
- the invention relates to
- nucleic acid fluorescent stain is an ethidium homodimer or a cyanine nucleic acid stain that stains only dead cells
- nucleic acid fluorescent stain is a cyanine-based nucleic acid fluorescent stain that stains only dead cells
- the agent that damages the cell membrane is Triton Xâ100 (trade name), Triton Xâ114 (trade name) or Nonidet pâ40 (trade name) force, which is at least one surfactant selected from the above [5], [6],
- nucleic acid fluorescent stain is ethidium homodimer or a cyanine nucleic acid fluorescent stain that stains only dead cells
- nucleic acid fluorescent stain is a cyanine-based nucleic acid fluorescent stain that stains only dead cells
- the drug that damages the cell membrane is selected from Triton Xâ100 (trade name), Triton Xâ114 (trade name) or Nonidet pâ40 (trade name)
- Triton Xâ100 trade name
- Triton Xâ114 trade name
- Nonidet pâ40 trade name
- a kit for measuring the number of viable cells and / or cell viability according to any one of [14] and [15] is provided.
- the invention relates to
- a means for supplying a nucleic acid fluorescent stain that stains only dead cells to the sample to be measured (b) Measuring the intensity of the fluorescent light emitted from the sample to be measured with the nucleic acid fluorescent stain (C) damaging cell membranes (D) at least means for measuring the intensity of the fluorescence emitted from the sample to be measured which has been treated with a nucleic acid fluorescent dye which stains only dead cells and which has been treated to damage the cell membrane.
- a device for measuring the number of viable cells and Z or cell viability characterized by comprising means for comparing the intensities of the above (b) and (d) for each of the measured intensities of the fluorescence;
- a drug injector for supplying a drug to a sample to be measured (A) a device that holds a drug that damages the cell membrane, (b) a device that holds a nucleic acid fluorescent stain that stains only dead cells, (c) a device that holds the above-mentioned device (a) or (b).
- a container such as a measuring cuvette or microplate with a stirrer capable of holding the sample to be measured, and ( e ) a spectrofluorometer as described in (18) to (21) above. Measuring device according to any one of the above; and
- a substance required for toxicity evaluation is allowed to act on cells, and then a nucleic acid fluorescent dye that stains only dead cells is allowed to act on the obtained measurement sample, and the intensity of fluorescence emitted from the measurement sample is determined.
- the intensity of the fluorescence emitted from the measurement sample subjected to the treatment with the nucleic acid fluorescent stain and the treatment to damage the cell membrane is measured, and the two intensities are compared to obtain the number of surviving cells and Z or cell survival.
- FIG. 1 is an example of the viable cell count measuring apparatus of the present invention.
- the present invention can be performed by a method in which the number of dead cells is measured for the same sample, and then the total number of cells is measured.
- FIG. 2 shows another example of the viable cell count measuring apparatus of the present invention.
- This device several measurement samples under the same conditions are prepared, and the number of dead cells is measured for the half of the samples by the above-mentioned method, and the nucleic acid fluorescent dye is applied to the remaining half of the samples.
- the present invention is carried out by a method in which the number of dead cells is measured for a sample in which the number of dead cells is determined in the same manner as in the above-mentioned method after performing the treatment and the treatment of damaging the cell membrane. be able to.
- FIG. 3 shows the relationship between the number of planktonic cells and the fluorescence intensity measured in the present invention. This shows that there is a proportional relationship between cell number and fluorescence intensity.
- FIG. 4 shows the relationship between the number of adherent cells and the fluorescence intensity. This shows that there is a proportional relationship between the cell number and the fluorescence intensity.
- the measurement sample to which the present invention can be applied may be a cell having no cell wall, and examples thereof include animal cells, some microbial cells, and protoplasts of microorganisms and plants from which cell walls have been removed.
- animal cells animal fluid cells (cells such as blood and lymph), cancer cells and the like can be mentioned as typical examples.
- animal fluid cells cells such as blood and lymph
- cancer cells cancer cells and the like can be mentioned as typical examples.
- These samples may be anything as long as they are in an environment where cells can survive, such as cells in a culture solution.
- cytotoxic drugs, pesticides, cosmetics, foods, etc. coexist in the living environment of these samples, some or all of the cells in the samples become dead cells. By measuring the number of surviving cells in such an environment, cytotoxicity can be evaluated.
- Nucleic acid fluorescent stains that stain only dead cells (1) pass through damaged cell membranes but do not pass through intact cell membranes, (2) emit or emit weak fluorescence when not bound to nucleic acids (3) It emits strong fluorescence when bound to nucleic acid.
- cationic nucleic acid fluorescent stains such as ethidium homodimer and cyanine nucleic acid stain; halogenated chemicals such as bromide chimide; and halogenated chemicals such as providium iodide can be used. Vibrant, stained only with ethidium homodimers or dead cells It is preferable to use a stain-based nucleic acid stain, and particularly desirable is a cyanine-based nucleic acid stain that stains only dead cells.
- cyanine nucleic acid stains that stain only dead cells include those described in US Pat. No. 5,321,130. Specifically, BOB ⢠â1 Iodide, BOBOâ 3 I od id es BO-PRO- 1 I od ide, BO-PRO- 3 I od ide, POPO- 1 I od ide, POPO- 3 I odide, PO-PRO-1 I od ide, PO-PRO- 3 Iodide, TOTO-1 Iodide, TOTO-3 Iodide, TO-PRO-1 Iodide, TO-PRO-3 Iodide, YOY 0-1 Iodide.YOYO-3 I odide, Y0-PR0-1 Iodide, Y0-PRO-3 Iodide (all trade names; manufactured by Molecular Probes), and the like.
- Fluorescence measurement wavelengths differ depending on the measurement conditions such as the type of cells to be measured and the type of target to be evaluated for cytotoxicity such as pharmaceuticals, agricultural chemicals, cosmetics, and foods, but each nucleic acid stain has its own unique Since it has an excitation wavelength and a fluorescence emission wavelength, it can be appropriately selected and used according to the measurement conditions.
- the nucleic acid fluorescent stain itself may have intrinsic fluorescence in addition to the target or culture medium for which cytotoxicity is to be evaluated, the background fluorescence intensity (Fb) derived from them is measured in advance using a fluorometer. It is necessary to keep.
- the nucleic acid fluorescent stain has a property of passing through a damaged cell membrane, that is, a cell membrane of a dead cell, and cannot pass through an intact cell membrane, that is, a cell membrane of a live cell.
- the staining agent When activated, selectively penetrates the dead cells, binds to the nucleic acid, and emits strong fluorescence.
- a method of damaging the cell membrane of the measurement sample there are a method of applying a drug that damages the cell membrane, and a method of damaging the cell membrane by a physical method such as applying ultrasonic waves.
- any agent that damages the cell membrane can be used as long as it damages the cell membrane of living cells and kills all living cells in the system.
- Surfactants acids such as hydrochloric acid and sulfuric acid; sodium hydroxide, and hydroxide Bases such as potassium and the like can be mentioned.
- a surfactant in the above-mentioned drugs.
- Nonionic surfactants such as ester-type nonionic surfactants such as Zwyn-20, Zwyn-1 80, and Span-1 20 (all trade names; manufactured by PI ERCECHEMI CAL);
- Nonidet p-4 Nonidet p-4
- Alcohol type nonionic surfactant such as 0 (trade name; manufactured by PI ERCECHEMI CAL); CHAP S, CHAPSO, BI GCHAP, DEOXY-BI GCHAP (all trade names; PI ERCECHEM)
- Cholic acid-type nonionic surfactants such as 1 CAL); hexyl / 3-D-glucopyranoside, octyl / 3-D-glucoviranoside, octyl- â -glucoside, octyl; S-thiogluviranoside, octyl Glycoside-type non-ionic surfactants such as glucoviranoside; N-lauroyl sarcosine, N-lauroyl sarcosine sodium, sodium lauryl sulfate, lithium lauryl sulfate, sodium dodecyl sulfate and the like; surfactants such as saponin, o Ginseng saponins, glycyl It is preferable to use a polyoxyethylene ether type nonionic surfactant or an alcohol type nonionic surfactant, such as ritin, glycyrrhizic acid or saponins such as s
- the drug should be dropped as a solution of a predetermined concentration into a culture solution containing stationary cells or the like, or into a stirred culture solution.
- a culture solution containing cells or the like can be gently added to a liquid containing the drug at a predetermined concentration, or the culture solution can be added and mixed with stirring.
- the addition can be carried out using, for example, a pipette, syringe (syringe), pipettor, dispenser, spot, or the like.
- the cells may only need to temporarily contact the drug that damages the cell membrane, for example, only immerse the drug in the liquid containing the drug.
- the method can be carried out by adding a predetermined amount of a solution of the drug to a culture solution according to a predetermined procedure using an automated device equipped with a microprocessor. It can be used by appropriately selecting from the following.
- the cell membrane is damaged by a physical method, it may not only damage the cell membrane but also destroy the DNA inside the cell. If necessary, examine the processing conditions. For example, when applying ultrasonic waves, it is possible to immerse the vibrator in the sample, or to put the sample in a lip-shaped container equipped with the vibrator. An apparatus capable of continuous processing can also be used, and can be used by appropriately selecting from apparatuses known in the art. To further damage the cell membrane, osmotic shock, freeze-thaw, etc. can be used. If the cell viability cannot be obtained directly from the measured values, create a new calibration curve for each treatment condition as needed and correct the measured values.
- the nucleic acid fluorescent stain enters the living cells, and the nucleic acid Binds and fluoresces. Therefore, fluorescence that is enhanced by the amount of fluorescence emitted from the living cells from the measurement sample is emitted.
- the intensity of the enhanced fluorescence (Ft ') with a fluorimeter, the total number of cells present in the measurement sample can be quantified. Then, the number of living cells can be determined by subtracting the number of dead cells from the total number of cells.
- the time interval between the previous measurement step and the subsequent measurement step becomes a problem.
- the time interval varies depending on various conditions such as a cell type to be measured, a nucleic acid fluorescent stain, and an agent that damages the cell membrane, but is preferably short, preferably within 2 hours, and more preferably within 1 hour. . Therefore, it is desirable to select which method is the most suitable for these conditions, taking into account various conditions such as the cell type to be measured, the fluorescent nucleic acid stain, and the agent that damages the cell membrane. .
- the cell viability can be calculated from the quantified values of the total cell number and the viable cell number. In addition, if the number of dead cells is estimated to be almost 0, it will be F1t. Therefore, when the fluorescence intensity is measured by simultaneously applying the nucleic acid fluorescent dye and the agent that damages the cell membrane at one time, one fluorescence
- the total number of cells that is, the number of viable cells can be quantified only by measurement. In the case of pharmaceuticals, agricultural chemicals, cosmetics, foods, etc., the cytotoxicity exerted by the number of viable cells and the cell viability may be evaluated depending on the values.For example, 50% of the viable cells will be dead cells. it may determine the concentration IC 5 D drugs, etc., but according to the method of the present invention, it is possible to assess their cytotoxic easily and efficiently.
- the cell viability can be directly measured without calculating the number of viable cells.
- the intensity of the fluorescence emitted by the measurement sample treated with a nucleic acid fluorescent stain that stains only dead cells, and the intensity of the fluorescence emitted by the measurement sample treated with the nucleic acid fluorescent stain and treated to damage the cell membrane The first step of measuring the strength and the first step (this step includes each treatment performed before each measurement) and the operations of the series of steps consisting of the second step comparing both intensities are combined to form a system. Output the number of viable cells or cell viability
- the present invention can be performed by a measuring instrument having a function. In the measuring device, a nucleic acid fluorescent stain for staining only dead cells and an agent for damaging the meniscus envelope were set in advance in order to perform each treatment performed before each measurement in the first step of the system.
- kits for measuring the number of viable cells and a kit for measuring Z or cell viability can be applied to such a measuring instrument, the measurement of the number of viable cells and Z or cell viability according to the present invention can be performed efficiently.
- the apparatus for automatically performing the measurement of the present invention include the apparatus shown in FIG. 1 and the apparatus shown in FIG.
- the device is referred to as a viable cell count measuring device, it may be understood as a cell viability measuring device or a viable cell count and / or cell viability measuring device. In the present description and in the claims, the device is to be understood in a broad sense.
- FIG. 1 shows an example of an apparatus for measuring the number of viable cells when the present invention is performed by a method of measuring the number of dead cells for the same sample and then measuring the total number of cells.
- the device consists of a spectrofluorometer built into the device, where the measuring cuvette with a stirrer (6), the excitation side spectrometer (14), the fluorescence spectrometer (15), a light source (10), a lens (5, 9 and 11), a polarizing plate (4 and 12), and a photomultiplier tube (13).
- 1 indicates a drug that damages the cell membrane
- 3 indicates a nucleic acid stain that stains only dead cells, and each drug is set in a tank or a detachable container in the apparatus.
- the drug set in these tanks or detachable containers can be injected into the measuring cuvette (6) with a stirrer by the drug injector (2).
- the equipment is equipped with valves and pumps (not shown) for appropriate control. Further, a washing pump, a drainage pump, a switching valve, an air pump for stirring, a nozzle, and the like can be provided as necessary.
- reference numeral 7 denotes a device for converting an analog signal into a digital signal
- reference numeral 8 denotes a control system.
- the measurement cuvette (6) can be continuously moved as necessary, and can automatically measure a plurality of cuvettes.
- the measuring cuvette (6) can be held in a thermostatic bath.
- the measurement cuvette (6) can be fixed so that the drug injector and the spectrofluorometer can be continuously moved as needed, and the measurement can be performed automatically.
- FIG. 2 several samples under the same conditions are prepared, and the number of dead cells is measured for the half of the samples by the method described above, while the remaining half of the samples are treated with a nucleic acid fluorescent dye.
- the present invention is carried out by performing a process of damaging the cell membrane, measuring the number of dead cells for a sample for determining the number of dead cells in the same manner as in the above method, and then measuring the total number of cells. In this case, an example of the viable cell counting device is shown.
- the device consists of a spectrofluorometer built into the device, where a 96-well microphone port plate with plate agitator (5), an excitation side spectrometer (15), It consists of a fluorescence spectrometer (16), a light source (11), a lens (7, 10 and 12), a polarizing plate (6 and 13) and a photomultiplier (14).
- 1 in the figure is a cell dilution suspension, which is set in a tank or a detachable container in the apparatus. In order to supply a suspension of uniform concentration from the tank to each well, a stirrer is attached to the tank or a detachable container.
- Each drug is set in a reservoir or a detachable container in the apparatus.
- the suspension or chemical set in these tanks or detachable containers is dispensed by a dispenser (3) to each well in a 96-well microphone port plate with plate agitator (5).
- Disposable tip at tip of dispenser (3) Or they are equipped with nozzles, which can be replaced or cleaned as needed.
- the tip of the dispenser (3) may be branched, and it is possible to dispense the drug to a plurality of sample wells at the same time.
- Reference numeral 8 in the figure denotes a device for converting an analog signal into a digital signal
- reference numeral 9 denotes a control system.
- the microplate (5) can be continuously moved as required, and can automatically measure a plurality of microplates. Further, the microplate is fixed, and the dispenser (3) and the spectrofluorometer can be continuously moved as required, so that the measurement can be performed automatically.
- the present invention is carried out by measuring the total number of cells after measuring the number of dead cells for the same sample, it is efficient to perform the measurement using the apparatus shown in FIG. An example of how to use this device is shown below.
- [1] Set the measurement sample such as cells in the culture solution in a measurement cuvette (6) equipped with a stirrer and stir.
- the nucleic acid stain (1) that stains only dead cells and the agent that damages the cell membrane (3) are set in advance in tanks in the apparatus.
- a nucleic acid stain (1) which stains only dead cells, is injected into a measurement cuvette (6) containing a measurement sample by a drug injector (2), and the measurement sample is stained. I do. Then, the intensity of the fluorescence emitted by this is measured with a spectrofluorometer. The measurement result is converted from an analog signal to a digital signal and sent to the control system (8).
- the amount used in (1) is automatically controlled in conjunction with the control system for fluorescence intensity measurement (8).
- the measurement sample is used as a cell-diluted suspension (1) in each well of a 96-well microplate (5) with a plate agitator using a dispenser (3). Dispense. After dispensing, stir the microplate with a plate stirrer. Also, the nucleic acid stain (2) for staining only dead cells and the agent (4) for damaging cell membranes are set in advance in the tank in the apparatus.
- [2] Dispense the nucleic acid stain (2), which stains only cells, into a 96-well microphone plate (5) in which the measurement sample is set using a dispenser, and stain the measurement sample. After that, the intensity of the fluorescence emitted from the sample in each well is measured with a spectrofluorometer. The measurement result is converted from an analog signal to a digital signal and sent to the control system (9). The amount of the nucleic acid stain (4) used to stain only dead cells is automatically controlled in conjunction with the control system (9) for measuring the fluorescence intensity.
- the dispenser is equipped with a separate dispensing tube for each drug, so that a single operation can dispense the drug to multiple wells. Wear.
- a test sample under the same conditions as those used in the measurement of [2] was set by a dispenser, using a dispenser for the drug (2) that damages the cell membrane and the nucleic acid dye (4) that stains only dead cells.
- the amount of the agent (2) that damages the cell membrane and the amount of the nucleic acid stain (4) that stains only dead cells are automatically controlled in conjunction with the control system for fluorescence intensity measurement (9).
- the measurement result is converted from an analog signal to a digital signal, sent to the control system (9), and the cell viability is measured in comparison with the measurement result in [2]. Also, if necessary, perform the above measurement on some samples whose cell numbers are known and have an appropriate cell number, and give a calibration curve to this device. Can be measured.
- a device for measuring the number of viable cells and / or cell viability is provided, each component of which can be used in automated immunoassays, automated biochemical assays, etc. It can be used by selecting and applying it from among those known in, or it can be used with appropriate modifications as needed.
- a programmed computer for example, a microcomputer, (a) a means for supplying a nucleic acid fluorescent stain for staining only dead cells to a sample to be measured, and (b) causing the nucleic acid fluorescent stain to act.
- Means for measuring the intensity of the fluorescence emitted from the sample to be measured (c) means for enabling the cell membrane to be damaged, and (d) the action of a nucleic acid fluorescent dye which stains only dead cells and damage to the cell membrane.
- the nucleic acid fluorescent dye for staining only the various dead cells described above is used.
- the above-mentioned various agents that damage cell membranes can be used in combination with each other.
- the combination of the above-mentioned nucleic acid fluorescent stain for staining only various dead cells and the above-mentioned various surfactants can be used. It is desirable to use.
- nucleic acid fluorescent dye for staining only dead cells and the various surfactants described above are mixed in advance as necessary.
- kits for measuring the number of viable cells and the Z or cell viability corresponding to the apparatus for measuring the number of viable cells shown in FIG. 1 or FIG.
- One of the desirable forms of the kit is a kit in which a nucleic acid stain for staining only dead cells and an agent for damaging the cell membrane are pre-filled in a detachable container of the viable cell counting device.
- the staining agent and the drug are filled in separate detachable containers, respectively, and if necessary, the same detachable container is used. It may be filled in a container.
- MOLT-4 cells human acute lymphoblastic leukemia cells: obtained from the Institute for Microbiology, Osaka University
- Culture solution is RPMI solution containing 10% fetal calf serum
- samples under good culture conditions in which the culture medium was changed appropriately when the cell concentration became high, and two samples on a plate (cultured without changing the culture medium) ( The poor culture conditions (samples (1) and (2)) were used as cell viability measurement samples.
- MOLT-4 human promyelocytic leukemia cells
- U933 human histiocytic lymphoma cells
- HT-1080 human fibrosarcoma cells
- the cell concentration of the measurement sample was diluted 2-fold with the culture solution to prepare a cell-diluted suspension, which was dispensed into each of the 96-well microplates at a rate of 180 â 1.
- FIG. 3 shows that there is a proportional relationship between the number of floating cells and the fluorescence intensity.
- HL-60 and U-937 have a proportional relationship between cell number and fluorescence intensity within the range of 1.25 â 10 4 to 4 â 10 5 cells.
- MOLT- 4 is proportional relationship between the cell number and fluorescence intensity in cell number 1. 2 5 xl (T â 2 xl 0 in five ranges.
- FIG. 4 shows that there is a proportional relationship between the number of adherent cells and the fluorescence intensity.
- â - 1 0 8 0 is proportional relationship between the cell number and fluorescence intensity in the number of cells 3 0 0 â 1 X 1 0 5 amino within range.
- the fluorescence intensity was measured using an MTP-32 Corona Microplate Reader-1 (manufactured by Corona Electric Co., Ltd.) under the measurement conditions of an excitation wavelength of 420 nm and a fluorescence emission wavelength of 460 nm. This measurement can be performed even if it is automated by the device shown in FIG.
- MOLT-4 cells were dispensed at 3 â 10 cells / 150 â 1 per cell.
- Triton X-100 (trade name) to each cell at 1/0/1 (final concentration: 0.05%), stir for about 30 seconds with a plate stirrer, and measure fluorescence To obtain F f.
- the number of surviving cells was measured by the MTT Atsey method with reference to pages 936 to 942, 1990, and the results are shown in Table 2.
- Table 3 shows the outline of the steps of measuring the number of viable cells by the method of the present invention and the MTT assay. Note that the above-described measurement according to the present invention can be performed by automation using the apparatus shown in FIG.
- TritonX- 100 (1%) 10 l / well 1 minute 4 37 ° C, 53 â 4C0 2 culture 3 hours
- the cytotoxicity of mitomycin C was calculated to be 2.2 â g / ml in the method according to the present invention. This value is only on the order of / g / ml, compared to the value measured by the MTT method (5.5 Ug / m â ), which is currently most commonly used for evaluating the cytotoxicity of drugs, and is acceptable in the art.
- the method according to the present invention can be sufficiently applied to the cytotoxicity evaluation by a drug.
- the present invention has the advantage that the cell viability at each drug concentration can be calculated at the same time, and a lot of information can be obtained in evaluating the drug efficacy.
- the time required for the measurement is about 5 minutes in the method according to the present invention, and the existing MT
- the use of a nucleic acid fluorescent dye that stains only dead cells and a drug that damages the cell membrane allow the number of viable cells and / or cell viability of multiple samples to be measured simply, quickly, and accurately. It can be used to evaluate cytotoxicity of pharmaceuticals, agricultural chemicals, cosmetics, foods, etc. In addition, its cytotoxicity can be easily and quickly evaluated.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
æ 现 æž çå现èæ°ã®æž¬å®æ¹æ³ æè¡åé
æ¬çºæã¯ã 现èã«å¯Ÿãã æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãäœçš ãããåŠçããã³çŽ°èèãæå·ãããåŠçãæœãããšã«ããã 簡䟿ã〠è¿
éã«å€æ€äœã®çå现èæ°ããã³ ZãŸãã¯çŽ°èçåçã枬å®ããæ¹æ³ã æäŸãããã®ã§ããã å»è¬ã 蟲è¬ã å粧åã é£åãªã©ã®ç 究éçºåéã å»åŠã è¬åŠã çç©åŠäžã®ç 究åéã ããã³èšåºçãªæ€æ»ïŒèšºæåéãªã© ã«ããã现èæ¯æ§ã®è©äŸ¡ãªã©ã«å©çšã§ããã èæ¯æè¡
å»è¬åã 蟲è¬ã å粧åã é£åãªã©ã®å®å
šæ§ã è¬å¹ãªã©ã¯ãããã®ãã ãŒã现èæ¯æ§ã«ãã£ãŠè©äŸ¡ãããããšãå€ãã ãã®çŽ°èæ¯æ§ã®ææšãšã ãŠçå现èæ°ã枬å®ãããããšãå€ãã çå现èæ°ãŸãã¯çŽ°èçåçã æ€åºå®éããæ¹æ³ãšããŠã¯ã â ããªãã³ãã«ãŒæè²æ³ã â¡ MTTã¢ãã» ã£æ³ (j ou rn a l o f Immuno l og i c a l M e t h o d sã 65å·ã 55ã 63é ã 1 983å¹ŽïŒ ã â¢ç±³åœç¹èš±å
¬å ±ç¬¬ 5 , 314ïŒ 805å·ã«èšèŒã®æ¹æ³ã ⣠Mo l e cu l a r Med i c i n e 32å·» 1 340ã 1 342é ã 1 995幎ã«èšèŒã®æ¹æ³ã â€ç±³ åœç¹èš±å
¬å ±ç¬¬ 5ïŒ 534ïŒ 4 16å·ã«èšèŒã®æ¹æ³ãªã©ãææ¡ãããŠãã c â ã®æ¹æ³ã¯ã é¡åŸ®é¡èŠéå
ã§ã æ»çŽ°èã®ã¿ãéè²ã«æè²ããè²çŽ ããªã ã³ãã«äžã«ãã€ãŠæè²ããã现èæ°ãèçŒã§èšæž¬ããæ¹æ³ã§ããã â¡ã® æ¹æ³ã¯ã MTTã现èå
ã®ã ãã³ã³ããªã¢ã®è±æ°ŽçŽ é
µçŽ ã®åºè³ªãšãªãã ãã®é
µçŽ åå¿ã®çµæçããé玫è²ã®ãã«ãã¶ã³ã®éãåžå
床èšã§å®éã
ããã®ã§ããã â¢ã®æ¹æ³ã¯ã åäžã®è©Šæäžã« 2çš®é¡ã®èå
ç©è³ª ïŒåã«ã» ã€ã³ A Mããã³ã§ããžã¥ã ãã¢ãã€ããŒïŒ ãäœçšããã ç现èã®çºã ãèå
ãšæ»çŽ°èã®çºããèå
ãšãåæã«èšæž¬ããããšã«ããã çå现è æ°ã枬å®ããæ¹æ³ã§ããã ã«ã«ã»ã£ã³ A Mã¯éåžžã»ãšãã©èå
ãçºã㪠ãç©è³ªã§ãããã ç现èå
ã§ã¯ãšã¹ãã©ãŒãŒã®äœçšã§ã«ã«ã»ã£ã³ã«å解 ããã 匷ãèå
ãçºããã ã§ããžã¥ã ãã¢ãã€ããŒã¯ã æå·éšãæã ã现èèã®ã¿ããééã§ããªãæ§è³ªãæã€æ žé
žèå
æè²å€ã§ããã æ»çŽ° èã®ã¿ã«ç¹ç°çã«äŸµå
¥ããŠæ žé
žãšçµåãã éåžžã®çŽ 4 0åã®èå
ãçºã ãã ãããã®æž¬å®æ³ã«ããã è¬å€çã«ãã现èæ¯æ§ããã«ããã¬ãŒãäž ã§ç°¡äŸ¿ãã€è¿
éã«æž¬å®ããããšãå¯èœãšãªã£ãã ãŸãã â£ã®æ¹æ³ã¯ã æ» çŽ°èã® D N Aã®ã¿ãæè²ãããšãŠåããããžã¥ã ãäœçšããã枬å®è©Šæ ã®çºããèå
ã®åŒ·åºŠãšã æ»çŽ°èãšç现èã® D N Aãæè²ãã H o e c h s t 3 3 2 5 8ãäœçšããã枬å®è©Šæã®çºããèå
ã®åŒ·åºŠãšãåã
枬 å®ãã 䞡匷床ã察æ¯ããããšã«ããã 现èçåçã枬å®ããæ¹æ³ã§ããã ããã«ã â€ã®æ¹æ³ã¯ã ç现èããã³æ»çŽ°èã®äž¡æ¹ã® D N Aãæè²ããç±³ åœç¹èš±å
¬å ±ç¬¬ 5ïŒ 4 3 6 , 1 3 4å·èšèŒã®ã·ã¡ãã³ç³»æ žé
žèå
æè²å€
( D y e I ) ãäœçšããã枬å®è©Šæãçºããèå
ã®åŒ·åºŠãšã æ»çŽ°èã® D N Aã®ã¿ãæè²ããç±³åœç¹èš±å
¬å ±ç¬¬ 5 , 3 2 1 , 1 3 0å·èšèŒã®ã·ã¡ äºã³ç³»æ žé
žèå
æè²å€ãŸãã¯ç现èã«äœçšããããšèå
ãçºããæè²å€
(äž¡è
ãç·ç§°ã㊠D y e Î ãšåŒãã§ããïŒ ãäœçšããã枬å®è©Šæãçº ããèå
ã®åŒ·åºŠãšãåã
枬å®ãã 䞡匷床ã察æ¯ããããšã«ããã 现èç åçã枬å®ããæ¹æ³ã§ããã
ãåãããªåããã â ã®æ¹æ³ã¯è²çŽ åãªãã³ãã«ãŒã«ããæè²ãå€å¥ãã ã®ãé£ããã èçŒã«ãããªããã°èšæž¬ãå°é£ã§ããã®ã§æž¬å®ã«éåžžã«æ éããããã â¡ããã³â¢ã®æ¹æ³ã¯åççã«é
µçŽ åå¿ã«äŸåããã®ã§ã 枬 å®æž©åºŠã æž¬å® p Hã é
µçŽ åå¿æéã 现èçš®ã«ããé
µçŽ 掻æ§ã®å·®ç°çã®åœ±
é¿ãåããããã ãŸãã â¡ã®æ¹æ³ã§ã¯é å¿åé¢æäœãå¿
èŠãªäžã é
µçŽ å å¿ã®çµæçããé£æº¶æ§ã®ããªã«ãã¶ã³ã溶解ããæäœãå¿
èŠã§ããã ⢠ã®æ¹æ³ã«ãããŠã¯ã ïŒ1) 现èå¹é€æ¶²äžã®è¡æž
ç±æ¥ã®ãšã¹ãã©ãŒãŒãã«ã« ã»ã£ã³ AMãå解ããã®ã§ã æ°åã®çŽ°èæŽæµã«ãã£ãŠè¡æž
ãé€ãå¿
èŠã ãããã æ»çŽ°èã¯æŽæµã«ããé€å€ãããããããã ç¡è¡æž
ã®çŽ°èå¹é€æ¶² ã䜿çšãã系以å€ã§ãªããšæ£ç¢ºãªæž¬å®ãè¡ããªãã ïŒ2) äºçš®é¡ã®èå
ã« ã€ããŠæž¬å®ãè¡ã£ãŠããããã 枬å®ãç
©éã«ãªããªã©ã®æ¬ ç¹ãããã ã ãã«ã â£ããã³â€ã®æ¹æ³ã«ãããŠã¯ã ïŒ1) 2çš®é¡ã®èå
ã«ã€ããŠæž¬å®ã è¡ããªããã°ãªããªãããæäœãç
©éã§ããã ïŒ2) 1ã€ã®è©Šæã« 2çš®é¡ ã®èå
è²çŽ ãäœçšãããŠçŽ°èçåçã枬å®ããå Žåã«ã¯ã åŸã§äœçšãã ãèå
è²çŽ ã«å¯Ÿãåã«äœçšãããèå
è²çŽ ãæªåœ±é¿ãåãŒãã ïŒ3) çå çãæ±ããããã«ã¯å枬å®æ¯ã«æ€éç·ãäœæããå¿
èŠããããªã©ã®æ¬ ç¹ ãããã çºæã®é瀺
æ¬çºæè
ã¯ã ïŒ1) 簡䟿ãã€è¿
éã«ã å€ãã®æ€äœã®è©Šæäžã®çå现èæ° ãæ£ç¢ºã«æž¬å®ã§ããã ïŒ2) 现èå¹é€æ¶²äžã«è¡æž
ãå
±åããŠãã枬å®è©Šæ ã«ã€ããŠã枬å®å¯èœã§ããã ïŒ3) 枬å®è©Šæã«å¯ŸããŠçŽ°èæŽæµã 现èé å¿ åé¢ã è²çŽ 溶解ãªã©ç
©éãªæäœãäžèŠã§ããã ïŒ4) 枬å®çµæãã 枬å®æž© 床ã æž¬å® P Hã è©Šè¬åå¿æéã 现èçš®ã«ããå·®ç°çã®åœ±é¿ãåãã«ãã ãªã©ã®æ¡ä»¶ãæºè¶³ã§ããçå现èæ°ã®æž¬å®æ¹æ³ãæäŸãããçš®ã
æ€èšã ãçµæã æ¬çºæãå®æããã
æ¬çºæã¯ã ïŒ1) æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãäœçšããã枬 å®è©Šæãçºããèå
ã®åŒ·åºŠãšã è©²æ žé
žèå
æè²å€ãäœçšãããåŠçãã ã³çŽ°èèãæå·ãããåŠçãæœãã枬å®è©Šæãçºããèå
ã®åŒ·åºŠãšãåã
枬å®ãã 䞡匷床ã察æ¯ããããšãç¹åŸŽãšããçå现èæ°ããã³ ZãŸãã¯
现èçåçã®æž¬å®æ¹æ³ããã³ ïŒ2 ) æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè² å€ãäœçšããã枬å®è©Šæãçºããèå
ã®åŒ·åºŠãšã 該æè²å€ããã³çŽ°èè ã i å·ããè¬å€ãäœçšããã枬å®è©Šæãçºããèå
ã®åŒ·åºŠãšãåã
æž¬å® ãã 䞡匷床ã察æ¯ããããšã§çå现èæ°ããã³ ZãŸãã¯çŽ°èçåçã®æž¬ å®ãè¡ãããã®æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ããã³çŽ°èèãæ å·ããè¬å€ããæ§æãããçå现èæ°ããã³ ZãŸãã¯çŽ°èçåç枬å®çš ãã ãã«é¢ããã ããå
·äœçã«ã¯ã æ¬çºæã¯ã
ã 1ã . æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãäœçšããã枬å®è©Šæ ãçºããèå
ã®åŒ·åºŠãšã è©²æ žé
žèå
æè²å€ãäœçšãããåŠçããã³çŽ°è èãæå·ãããåŠçãæœãã枬å®è©Šæãçºããèå
ã®åŒ·åºŠãšãåã
æž¬å® ãã 䞡匷床ã察æ¯ããããšãç¹åŸŽãšããçå现èæ°ããã³/ãŸãã¯çŽ°è çåçã®æž¬å®æ¹æ³ïŒ
ã2ã . (0 枬å®è©Šæã«å¯Ÿãæ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ã äœçšããã ãã®çµæçºããããèå
ã®åŒ·åºŠã枬å®ããåŸã ïŒÎ )次ãã§ã ãã®è©Šæã®çŽ°èèãæå·ãããåŠçãæœãã 现èãæ»æ»
ãããããšã«ã ãå¢åŒ·ãããèå
ã®åŒ·åºŠã枬å®ããäžèš Î ã èšèŒã®æž¬å®æ¹æ³ïŒ ã3ã . (0 枬å®è©Šæã«å¯Ÿãæ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ã äœçšããã ãã®ãã®ãçºããèå
ã®åŒ·åºŠã枬å®ãã ïŒÎ)å¥ã®æž¬å®è©Šæ㫠察ãè©²æ žé
žèå
æè²å€ãäœçšãããåŠçããã³çŽ°èèãæå·ãããåŠç ãæœãã ãã®ãã®ãçºããèå
ã®åŒ·åºŠã枬å®ããäžèš ã 1ã èšèŒã®æž¬å® æ¹æ³ïŒ
ã4ã . åèšæ žé
žèå
æè²å€ãã éœã€ãªã³æ§æ žé
žèå
æè²å€ã§ããäž èš ã1ã ã ã3ã ã®ããããäžèšèŒã®æž¬å®æ¹æ³ïŒ
ã5ã . 现èèãæå·ããè¬å€ãçšããŠçŽ°èèãæå·ãããäžèš ã 1ã
ã ã4ã ã®ããããäžèšèŒã®æž¬å®æ¹æ³ïŒ
ã6ã . 现èèãæå·ããè¬å€ãçé¢æŽ»æ§å€ã§ããäžèš ã5ã èšèŒã® 枬å®æ¹æ³ïŒ
ã7ã . æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãäœçšããã枬å®è©Šæ ãçºããèå
ã®åŒ·åºŠãšã è©²æ žé
žèå
æè²å€ãäœçšãããåŠçããã³çŽ°è èãæå·ãããåŠçãæœãã枬å®è©Šæãçºããèå
ã®åŒ·åºŠãšãåã
æž¬å® ãã 䞡匷床ã察æ¯ããããšããæãäžé£ã®å·¥çšäžã®åã
ã®æäœãèªåå ãããè£
眮ã«ãŠè¡ãäžèš ã1ã ã ã6ã ã®ããããäžèšèŒã®æž¬å®æ¹æ³ïŒ åã³
ã8ã . æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãäœçšããã枬å®è©Šæ ãçºããèå
ã®åŒ·åºŠãšã 該æè²å€ããã³çŽ°èèãæå·ããè¬å€ãäœçšã ãã枬å®è©Šæãçºããèå
ã®åŒ·åºŠãšãåã
枬å®ãã 䞡匷床ã察æ¯ããã ãšã§çå现èæ°ããã³ ZãŸãã¯çŽ°èçåçã®æž¬å®ãè¡ãããã®æ»çŽ°èã® ã¿ãæè²ããæ žé
žèå
æè²å€ããã³çŽ°èèãæå·ããè¬å€ããæ§æãã ãçå现èæ°ããã³ ZãŸãã¯çŽ°èçåç枬å®çšãã ããæäŸããã ããã«å¥ã®æ
æ§ãšããŠã¯ã æ¬çºæã¯
ã9ã . åèšæ žé
žèå
æè²å€ãã§ããžã¥ã ãã¢ãã€ããŒãŸãã¯æ»çŽ° èã®ã¿ãæè²ããã·ã¡ãã³ç³»æ žé
žèå
æè²å€ã§ããäžèš ã1ã ã ã3ã ã®ããããäžèšèŒã®æž¬å®æ¹æ³ïŒ
ã1 0ã . åèšæ žé
žèå
æè²å€ãæ»çŽ°èã®ã¿ãæè²ããã·ã¡ãã³ç³»æ ž é
žèå
æè²å€ã§ããäžèš ã1ã ã ã3ã ã®ããããäžèšèŒã®æž¬å®æ¹æ³ïŒ
ã1 1ã . 现èèãæå·ããè¬å€ãããªãªãã·ãšãã¬ã³åéã€ãªã³æ§ çé¢æŽ»æ§å€ãŸãã¯ã¢ã«ã³ãŒã«åéã€ãªã³æ§çé¢æŽ»æ§å€ã§ããäžèš ã5ã ã
ã6ã ã ã9ã åã³ ã1 0ã ã®ããããäžèšèŒã®æž¬å®æ¹æ³ïŒ
ã1 2ã . 现èèãæå·ããè¬å€ãã㪠ãã³ Xâ 1 0 0 (åååïŒ ã
ã㪠ãã³ Xâ 1 1 4 (åååïŒ ãŸãã¯ãããã ã pâ 4 0 (åååïŒ åã ãéžã°ããå°ãªããšã 1çš®ã®çé¢æŽ»æ§å€ã§ããäžèš ã5ã ã ã6ã ã
ã9ã åã³ ã1 0ã ã®ããããäžèšèŒã®æž¬å®æ¹æ³ïŒ
ã1 3ã . åèšæ žé
žèå
æè²å€ãã éœã€ãªã³æ§æ žé
žèå
æè²å€ã§ãã äžèš ã8ã èšèŒã®çå现èæ°ããã³/ãŸãã¯çŽ°èçåç枬å®çšãã ã ïŒ
ã1 4ã . åèšæ žé
žèå
æè²å€ãã§ããžã¥ã ãã¢ãã€ãäžãŸãã¯æ» 现èã®ã¿ãæè²ããã·ã¡ãã³ç³»æ žé
žèå
æè²å€ã§ããäžèš ã8ã èšèŒã® çå现èæ°ããã³/ãŸãã¯çŽ°èçåç枬å®çšãã å ïŒ
ã1 5ã . åèšæ žé
žèå
æè²å€ãæ»çŽ°èã®ã¿ãæè²ããã·ã¡ãã³ç³»æ ž é
žèå
æè²å€ã§ããäžèš ã8ã èšèŒã®çå现èæ°ããã³ ZãŸãã¯çŽ°èç åç枬å®çšãã ã ïŒ
ã1 6ã . 现èèãæå·ããè¬å€ãããªãªãã·ãšãã¬ã³åéã€ãªã³æ§ çé¢æŽ»æ§å€ãŸãã¯ã¢ã«ã³ãŒã«åéã€ãªã³æ§çé¢æŽ»æ§å€ã§ããäžèš ã8ã ã
ã1 3ã ã ã1 4ã åã³ ã1 5ã ã®ããããäžèšèŒã®çå现èæ°ããã³ ZãŸãã¯çŽ°èçåç枬å®ãã ã ïŒåã³
ã 1 7ã . 现èèãæå·ããè¬å€ãã㪠ãã³ Xâ 1 0 0 (åååïŒ ã å㪠ãã³ Xâ 1 1 4 (åååïŒ ãŸãã¯ãããã ã pâ 4 0 (åååïŒ ã ãéžã°ããå°ãªããšã 1çš®ã®çé¢æŽ»æ§å€ã§ããäžèš ã 8ã ã ã 1 3ã ã
ã1 4ã åã³ ã1 5ã ã®ããããäžèšèŒã®çå现èæ°ããã³/ãŸãã¯çŽ° èçåç枬å®çšãã åãæäŸããã ããã«å¥ã®æ
æ§ãšããŠã¯ã æ¬çºæã¯
U 8ã . (a) æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ã枬å®å¯Ÿè±¡è©Š æã«äŸçµŠããæ段ã ïŒb) è©²æ žé
žèå
æè²å€ãäœçšããã枬å®å¯Ÿè±¡è©Šæ ãçºãã泶å
ã®åŒ·åºŠã枬å®ããæ段ã ïŒc) 现èèãæå·ãããããšã
å¯èœã«ããæ段ã ïŒd) æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãäœçšã ãäžã€çŽ°èèãæå·ãããåŠçãæœãã枬å®å¯Ÿè±¡è©Šæãçºããèå
ã®åŒ· 床ã枬å®ããæ段ãã å°ãªããšãåããŠããäžã€æž¬å®ãããåã
ã®èå
ã®åŒ·åºŠã«ã€ãäžèš ïŒb) ãšäžèš ïŒd) ã®äž¡åŒ·åºŠã察æ¯ããæ段ãåã㊠ããããšãç¹åŸŽãšããçå现èæ°ããã³ ZãŸãã¯çŽ°èçåçã®æž¬å®è£
眮ïŒ
ã1 9ã . (i) 枬å®è©Šæã«å¯Ÿãæ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ ãäœçšããã ãã®çµæçºããããèå
ã®åŒ·åºŠã枬å®ããåŸã ïŒii)次ãã§ã ãã®è©Šæã®çŽ°èèãæå·ãããåŠçãæœãã 现èãæ»æ»
ãããããšã«ã ãå¢åŒ·ãããèå
ã®åŒ·åºŠã枬å®ããããšãè¡ãããšãç¹åŸŽãšããäžèš
ã 1 8ã èšèŒã®æž¬å®è£
眮ïŒ
ã20ã . äžèšïŒi) åã³ïŒH)ãèªååããã圢æ
ã§è¡ãããã«ããã ããšãç¹åŸŽãšããäžèš ã1 8ã ãŸã㯠ã1 9ã èšèŒã®æž¬å®è£
眮ïŒ
ã2 1ã . ãã€ã¯ãããã»ããµãŒã䜿çšããŠäºãä¿åãããŠãããã ã°ã©ã ã«åŸãèªåçã«å¶åŸ¡ãããŠååŠçãè¡ãããããã«ãããããšã ç¹åŸŽãšããäžèš ã2 0ã èšèŒã®æž¬å®è£
眮ïŒ
ã22ã . (a) 现èèãæå·ããè¬å€ãä¿æããè£
眮ã ïŒb) æ»çŽ° èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãä¿æããè£
眮ã ïŒc) äžèšè£
眮 ïŒa) ããã㯠ïŒb) ããã®è¬å€ã枬å®å¯Ÿè±¡è©Šæã«äŸçµŠããè¬å€æ³šå
¥åšã
(d) 枬å®å¯Ÿè±¡è©Šæãä¿æã§ããæªæè£
眮ä»ã枬å®ãã¥ã¹ã ãããã㯠ãã€ã¯ããã¬ãŒããªã©ã®å®¹åšã åã³ ïŒe) åå
èå
å
床èšãåããããš ãç¹åŸµãšããäžèš ã1 8ã ã ã2 1ã ã®ããããäžèšèŒã®æž¬å®è£
眮ïŒå ã³
ã23ã . (a) åäžã®æž¬å®å¯Ÿè±¡è©Šæã«å¯ŸããŠã ïŒi) æ»çŽ°èã®ã¿ãæ è²ããæ žé
žèå
æè²å€ãäœçšããã ãã®çµæçºããããèå
ã®åŒ·åºŠã枬 å®ããåŸã ïŒii)次ãã§ã ãã®è©Šæã®çŽ°èèãæå·ãããåŠçãæœãã 现 èãæ»æ»
ãããããšã«ããå¢åŒ·ãããèå
ã®åŒ·åºŠã枬å®ããããšãè¡ã
ããšãå¯èœã«ããè£
眮ã ããã㯠ïŒb ) ( i ) ãã枬å®å¯Ÿè±¡è©Šæã«å¯Ÿã㊠æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãäœçšããã ãã®çµæçºãããã èå
ã®åŒ·åºŠã枬å®ãã ïŒi i )ãããšã¯å¥ã®æž¬å®å¯Ÿè±¡è©Šæã«å¯ŸããŠè©²æ»çŽ°è ã®ã¿ãæè²ããæ žé
žèå
æè²å€ãäœçšããäžã€çŽ°èèãæå·ãããåŠç ãæœãã ãã®çµæçºããããèå
ã®åŒ·åºŠã枬å®ããããšãè¡ãããšãå¯ èœã«ããè£
眮ãåããããšãç¹åŸµãšããäžèš ã1 8ã èšèŒã®æž¬å®è£
眮ã æäŸãããã ããã«å¥ã®æ
æ§ãšããŠã¯ã æ¬çºæã¯
ã2 4ã . æ¯æ§è©äŸ¡ã®æ±ããããç©è³ªã现èã«äœçšãããã 次ã«åŸã ãã枬å®è©Šæã«æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãäœçšããã 該枬 å®è©Šæãçºããèå
ã®åŒ·åºŠãšã è©²æ žé
žèå
æè²å€ãäœçšãããåŠçãã ã³çŽ°èèãæå·ãããåŠçãæœãã枬å®è©Šæãçºããèå
ã®åŒ·åºŠãšãåã
枬å®ãã 䞡匷床ã察æ¯ããããšã«ããã çå现èæ°ããã³ ZãŸãã¯çŽ°è çåçã枬å®ããããšãç¹åŸŽãšããç©è³ªã®æ¯æ§è©äŸ¡æ¹æ³ïŒ
ã2 5ã . (i) æ¯æ§è©äŸ¡ã®æ±ããããç©è³ªã现èã«äœçšãããã ïŒÎ ) åŸããã枬å®è©Šæã«å¯Ÿãæ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãäœçšã ãã ãã®çµæçºããããèå
ã®åŒ·åºŠã枬å®ããåŸã ïŒi i i) 次ãã§ã ãã® è©Šæã®çŽ°èèãæå·ãããåŠçãæœãã 现èãæ»æ»
ãããããšã«ããå¢ åŒ·ãããèå
ã®åŒ·åºŠã枬å®ããäžèš ã2 4ã èšèŒã®æ¯æ§è©äŸ¡æ¹æ³ïŒåã³
ã2 6ã . (i ) æ¯æ§è©äŸ¡ã®æ±ããããç©è³ªã现èã«äœçšãããã ïŒi i) 枬å®è©Šæã«å¯Ÿãæ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãäœçšããã ãã® ãã®ãçºããèå
ã®åŒ·åºŠã枬å®ãã ïŒH i) å¥ã®æž¬å®è©Šæã«å¯Ÿãè©²æ žé
žè å
æè²å€ãäœçšãããåŠçããã³çŽ°èèãæå·ãããåŠçãæœãã ãã® ãã®ãçºããèå
ã®åŒ·åºŠã枬å®ããäžèš ã2 4ã èšèŒã®æ¯æ§è©äŸ¡æ¹æ³ã æäŸããã
å³é¢ã®ç°¡åãªèª¬æ
第 1å³ã¯ã æ¬çºæã®çå现èæ°æž¬å®è£
眮ã®äžäŸã§ããã æ¬è£
眮ã§ã¯ã åäžè©Šæã«ã€ããŠæ»çŽ°èæ°ã®æž¬å®ãè¡ã£ãåŸã å
šçŽ°èæ°ã®æž¬å®ãè¡ãæ¹ æ³ã§æ¬çºæãè¡ãããšãã§ããã
1âŠâŠçŽ°èèãæå·ããè¬å€ 2âŠâŠè¬å€æ³šå
¥åš
3âŠâŠæ»çŽ°èã®ã¿ãæè²ããæ žé
žæè²å€ 10âŠâŠå
æº
6âŠâŠæªæè£
眮ä»ã枬å®ãã¥ãã ã 5ã 9åã³ 11âŠâŠã¬ã³ãº
7âŠâŠã¢ãå£ã°ä¿¡å·ãããžã¿ã«ä¿¡å·ã«å€æããè£
眮
4åã³ 12âŠâŠåå
æ¿ 13âŠâŠå
é»ååå¢ç®¡
8âŠâŠå¶åŸ¡ã·ã¹ãã 14âŠâŠå±å
åŽåå
åš 15âŠâŠèå
åå
åš ç¬¬ 2å³ã¯ã æ¬çºæã®çå现èæ°æž¬å®è£
眮ã®å¥ã®äžäŸã§ããã æ¬è£
眮㧠ã¯ã åäžæ¡ä»¶ã®æž¬å®è©Šæãäœç¹ãçšæãã ãã®äžã®åæ°ã®è©Šæã«ã€ãå èšæ¹æ³ã§åèšæ»çŽ°èæ°ã枬å®ãã äžæ¹æ®ãã®åæ°ã®è©Šæã«æ žé
žèå
æè² å€ãäœçšãããåŠçããã³çŽ°èèãæå·ãããåŠçãæœãã åèšæ¹æ³ã® å Žåãšåæ§ã«æ»çŽ°èæ°ãæ±ããå Žåã®è©Šæã«ã€ããŠæ»çŽ°èæ°ã®æž¬å®ãè¡ã€ ãåŸã å
šçŽ°èæ°ã®æž¬å®ãè¡ãæ¹æ³ã§æ¬çºæãè¡ãããšãã§ããã
1âŠâŠçŽ°èåžéæžæ¿æ¶² 2âŠâŠçŽ°èèãæå·ããè¬å€
3âŠâŠåæ³šåš 4âŠâŠæ»çŽ°èã®ã¿ãæè²ããæ žé
žæè²å€
5âŠâŠãã¬ãŒãæªæåšä»ã 9 6ãŠã§ã«ãã€ã¯å£ãã¬ãŒã
6åã³ 13âŠâŠåå
æ¿ 7ã 10åã³ 12âŠâŠã¬ã³ãº
8âŠâŠã¢ãå£ã°ä¿¡å·ãããžã¿ã«ä¿¡å·ã«å€æããè£
眮
9âŠâŠå¶åŸ¡ã·ã¹ãã 11âŠâŠå
æº âŠâŠå±å
åŽåå
åš
16âŠâŠèå
åå
åš 14âŠâŠå
é»ååå¢ç®¡
第 3å³ã¯ã æµ®éæ§çŽ°èã®çŽ°èæ°ãšæ¬çºæã§æž¬å®ããèå
匷床ãšã®éã® é¢ä¿ã瀺ããŠããã 现èæ°ãšèå
匷床ãšã®éã«æ¯äŸé¢ä¿ãããããšã瀺 ããŠããã 第 4å³ã¯ã æ¥çæ§çŽ°èã®çŽ°èæ°ãšèå
匷床ãšã®éã®é¢ä¿ã瀺ããŠããã 现èæ°ãšèå
匷床ãšã®éã«æ¯äŸé¢ä¿ãããããšã瀺ããŠããã çºæãå®æœããããã®æè¯ã®åœ¢æ
æ¬çºæãé©çšããããšã®ã§ãã枬å®è©Šæã¯ã 现èå£ãæããªã现è㧠ããã°ããã äŸãã°ã åç©çŽ°èã äžéšã®åŸ®çç©çŽ°èã 现èå£ãé€å»ãã ã埮çç©ãæ€ç©ã®ãã ããã©ã¹ããªã©ãæããããã ç¹ã«åç©ã®çŽ°è㧠ããã°äœã§ã枬å®è©Šæãšããããšãã§ãã äŸãã°åç©ã®äœæ¶²çŽ°è ïŒè¡æ¶²ã ãªã³ã液ãªã©ã®çŽ°èïŒ ã ç现èãªã©ãå
žåçãªãã®ãšããŠæããããšã ã§ããã ãããè©Šæã¯çŽ°èãçåã§ããç°å¢ã«ãããã®ãªãäœã§ãããã äŸãã°å¹é€æ¶²äžã®çŽ°èãªã©ãæããããã ãããè©Šæã®çåç°å¢å
ã«çŽ° èæ¯æ§ãããå»è¬åã 蟲è¬ã å粧åã é£åãªã©ãå
±åãããå Žåã è©Šæ äžã®äžéšãããã¯å
šéšã®çŽ°èãæ»çŽ°èãšãªãã ãã®ãããªç°å¢å
ã§çå 现èæ°ã枬å®ãããšã 现èæ¯æ§ã®è©äŸ¡ãè¡ãããšãã§ããã
æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãšã¯ã ïŒ1) æå·ãã现èèã¯é éãããã ç¡å·ã®çŽ°èèã¯ééããªãã ïŒ2) æ žé
žãšçµåããŠããªãç¶æ
ã§ã¯åŒ±ãèå
ãçºããããããã¯èå
ãã»ãšãã©çºããªãã ïŒ3) æ žé
žãš çµåãããšåŒ·ãèå
ãçºãããªã©ã®ç¹åŸŽãæã€ãã®ãæå³ããã å
·äœç ã«ã¯ã ã§ããžã¥ã ãã¢ãã€ããŒã ã·ã¡ãã³ç³»æ žé
žæè²å€ãªã©ã®éœã£ã© ã³æ§æ žé
žèå
æè²å€ïŒèåå·¥ããžã¥ã ã®ãããªããã²ã³åå·¥ããžã¥ã ïŒ ã§ã¥åããããžãŠãŠã ã®ãããªããã²ã³åããããžãŠãŠã ãªã©ã䜿çšã§ ããåãã ã§ããžã¥ã ãã¢ãã€ãäžãŸãã¯æ»çŽ°èã®ã¿ãæè²ããã·ã¡ã
ã³ç³»æ žé
žæè²å€ã䜿çšããã®ãæãŸããã æ»çŽ°èã®ã¿ãæè²ããã·ã¡ã ã³ç³»æ žé
žæè²å€ãç¹ã«æãŸããã æ»çŽ°èã®ã¿ãæè²ããã·ã¡ãã³ç³»æ žé
ž æè²å€ãšããŠã¯ã ç±³åœç¹èš±å
¬å ±ç¬¬ 5ïŒ 32 1, 1 30å·ã«èšèŒã®ãã®ãª ã©ãæãããã å
·äœçã«ã¯ BOBâŠâ 1 I od i d eã BOBOâ 3 I od i d es BO- PRO- 1 I od i d e, BO-PRO- 3 I od i d e, POPO- 1 I od i d e, POPO- 3 I o d i d eã PO - PRO - 1 I od i d e, PO-PRO- 3 I od i deã TOTO - 1 I od i d eã TOTO - 3 I od i deã TO - PRO- 1 I o d i d eã TO - PRO - 3 I od i d e, YOY 0 - 1 I od i de. YOYO- 3 I o d i d eã Y 0 - P R 0 - 1 I od i deã Y0â PROâ 3 I od i d e (以äžå
šãŠåååïŒ M o l e c u l a r P rob e sç€Ÿè£œïŒ ãªã©ãæããããã 枬å®ãã¹ã 现èã®çš®é¡ãå»è¬åã 蟲è¬ã å粧åã é£åãªã©çŽ°èæ¯æ§ãè©äŸ¡ãã¹ã察 象ã®çš®é¡ãªã©ã®æž¬å®æ¡ä»¶ã®éãã«ããã èå
枬å®æ³¢é·ã¯ç°ãªããã åæ ž é
žæè²å€ã¯ã ããããåºæã®å±èµ·æ³¢é·ã èå
æŸå°æ³¢é·ãæããã®ã§ã 枬 å®æ¡ä»¶ã«å¿ãé©åãªãã®ãé©å®éžæããŠäœ¿çšããããšãã§ããã ãŸãã 现èæ¯æ§ãè©äŸ¡ããã察象ãå¹é€æ¶²ã®ã»ãæ žé
žèå
æè²å€èªäœãåºæã® èå
ãæã€å Žåãããã®ã§ã äºããããã«ç±æ¥ããããã¯ã°ã©ãŠã³ãã® èå
匷床 ïŒFb) ãèå
枬å®èšã§æž¬å®ããŠããå¿
èŠãããã
åèšæ žé
žèå
æè²å€ã¯ã æå·ãã现èèå³ã¡æ»çŽ°èã®çŽ°èèã¯ééã ãå \ ç¡å·ã®çŽ°èèå³ã¡ç现èã®çŽ°èèã¯ééã§ããªãæ§è³ªãæã€ã®ã§ã ç现èããã³æ»çŽ°èãå
±åããè©Šæã«ãã®æè²å€ãäœçšããããšã æ»çŽ° èã«æè²å€ãéžæçã«äŸµå
¥ãã æ žé
žãšçµåããŠåŒ·ãèå
ãçºããããã ãã®èå
ã®åŒ·åºŠ ïŒFd' ) ãèå
枬å®èšã§æž¬å®ããããšã«ããæ»çŽ°èæ° ãå®éããããšãã§ããã å
·äœçã«ã¯ Fd = Fd' â Fbãšããèšç®åŒ ã«ããã æ»çŽ°èæ°ã«çžåœããèå
匷床 ïŒFd) ãæ±ãã ãã®å€ããæ»çŽ°
èæ°ãæ€éç·ãªã©ã«ãã€ãŠå®éããããšãã§ããã ãŸãæ»çŽ°èæ°ãæ±ã ãããšãªãçŽæ¥çŽ°èçåçãæ±ããããšãã§ããã
枬å®è©Šæã®çŽ°èèãæå·ããæ¹æ³ãšããŠã¯ã 现èèãæå·ãããè¬å€ ãäœçšãããæ¹æ³ã è¶
é³æ³¢ãäœçšããããªã©ã®ç©ççæ¹æ³ã«ãã€ãŠçŽ°è èãæå·ãããæ¹æ³ãªã©ãããã
现èèãæå·ãããè¬å€ã¯ã ç现èã®çŽ°èèã«å·å®³ãäžãç³»å
ã®å
šãŠ ã®ç现èãæ»æ»
ãããè¬å€ã§ããã°äœã§ãããã çé¢æŽ»æ§å€ïŒå¡©é
žã ç¡« é
žãªã©ã®é
žïŒæ°Žé
žåãããªãŠã ã æ°Žé
žååãªãŠã ãªã©ã®ãããªå¡©åºãªã© ãæããããã ãåãããªå <ãã åŸèšèå
匷床ã®æž¬å®ãæçã«è¡ãããã« ã¯åè¿°ã®è¬å€äžã çé¢æŽ»æ§å€ã䜿çšããã®ãæãŸããã å
·äœçã«ã¯ã㪠ãã³ Xâ 1 00ã ã㪠ãã³ Xâ 1 14ã ã㪠ãã³ Xâ 305ã ã㪠ãã³ X - 405ã B r i jâ 35ã B r i jâ 56ã B r i jâ 58 (ä»¥äž å
šãŠåååïŒ P I ERCECHEMI C A Lç€Ÿè£œïŒ ãªã©ã®ããªã©ãã·ã§ ãã¬ã³ãšãŒãã«åéã€ãªã³æ§çé¢æŽ»æ§å€ïŒ ããŠã€ãŒã³â 20ã ããŠã€äž ã³ãŒ 80ã ã¹ãã³äž 20 (以äžå
šãŠåååïŒ P I ERCECHEMI C ALç€Ÿè£œïŒ ãªã©ã®ãšã¹ãã«åéã€ãªã³æ§çé¢æŽ»æ§å€ïŒ ãããã ã pâ 4
0 (åååïŒ P I ERCECHEMI CALç€Ÿè£œïŒ ã®ãããªã¢ã«ã³ãŒã« åéã€ãªã³æ§çé¢æŽ»æ§å€ïŒ CHAP Sã CHAPSOã B I GCHAPã DEOXY-B I GCHAP (以äžå
šãŠåååïŒ P I ERCECHEM
1 CALç€Ÿè£œïŒ ãªã©ã®ã³ãŒã«é
žåéã€ãªã³æ§çé¢æŽ»æ§å€ïŒãžãã·ã«ãŒ /3 â Dâã°ã«ã³ãã©ãã·ãã ã©ã¯ãã«ãŒ /3â Dâã°ã«ã³ãã©ãã·ãã ã©ã¯ ãã«ãŒ ^ãŒã°ã«ã³ã·ãã ã©ã¯ãã«ãŒïŒ Sâãã©ã°ã«ãã©ãã·ãã ã©ã¯ãã« ã°ã«ã³ãã©ãã·ããªã©ã®ã°ãªã³ã·ãåéã£ã©ã³æ§çé¢æŽ»æ§å€ïŒ Nâã©ãŠ ãã€ã«ãµã«ã³ã·ã³ã Nâã©ãŠãã€ã«ã¶ã«ã³ã·ã³ã ã ãªãŠã ã ã©ãŠãªã«ç¡« é
žãããªãŠã ã ã©ãŠãªã«ç¡«é
žãªããŠã ã ããã·ã«ç¡«é
žãããªãŠã ãªã©ã® é°ã£ã©ã³çé¢æŽ»æ§å€ïŒãµããã³ã ã©ã¿ããã³ãžã³ãµãäºã³é¡ã ã°ãªãã«
ãªãã³ã ã°ãªãã«ãªãã³é
žãŸãã¯ãµã€ã³ãµããã³é¡ãªã©ã®ãµããã³é¡ã æããããåãã ããªãªãã·ãšãã¬ã³ãšãŒãã«åéã€ãªã³æ§çé¢æŽ»æ§å€ãŸ ãã¯ã¢ã«ã³ãŒã«åéã£ã©ã³æ§çé¢æŽ»æ§å€ã䜿çšããã®ãæãŸããã ã㪠ãã³ Xâ 1 0 0 (åååïŒ ã ã㪠ãã³ Xâ 1 1 4 (åååïŒ ãŸãã¯ãã ãã ã pâ 4 0 (åååïŒ ã䜿çšããã®ãç¹ã«æãŸããã ããã现èè ãæå·ããè¬å€ã¯åç¬ã§ãããã¯æ··çšããŠäœ¿çšããããšãã§ããã
现èèãæå·ããè¬å€ãäœçšãããå Žåã 該è¬å€ã¯æå®ã®æ¿åºŠã®æº¶æ¶² ãšããŠã é眮ããã现èãªã©ãå«æããå¹é€æ¶²äžã«æ»Žäžããããã æªæ ãããŠããå¹é€æ¶²äžã«æ»Žäžããããããããšã§äœçšãããããšãã§ããã ãŸã該è¬å€ãæå®ã®æ¿åºŠã§å«æãã液äœäžã«ã 现èãªã©ãå«æããå¹é€ 液ãéãã«å ãããã ãããã¯æªæäžã«å¹é€æ¶²ãå ããŠã æ··åããããš ãã§ããã ããããå Žåã äŸãã°ããºã ãã 泚å°åš ïŒã·ãªã³ãžïŒ ã ããºã ã¿ãŒã å泚åšã ã¹ã㣠ããªã©ã䜿çšããŠæ·»å ãè¡ãããšãã§ããã ãŸãã 现èã¯è©²çŽ°èèãæå·ããè¬å€ã«äžæçã«æ¥è§Šã äŸãã°è©²è¬å€å«æ液㫠浞挬ããã ãã§ããããšãããã 奜ãŸããã¯ã ãã€ã¯ãããã»ããµãŒã åããèªååãããè£
眮ãçšããŠäºã決ããããæé ã«åŸã該è¬å€ã®æº¶ 液ãå¹é€æ¶²äžã«æå®éå ããããšã«ããè¡ãããšãã§ãã åœè©²åéã§ç¥ ãããè£
眮ã®äžããéžãã§é©å®å©çšããŠçšããããšãã§ããã
ç©ççæ¹æ³ã«ãã£ãŠçŽ°èèãæå·ãããå Žåã 现èèãæå·ããã°ã ãã§ãªã现èå
ã® D N AçãŸã§ç Žå£ããå Žåãããã å¿
èŠã«å¿ããŠã åŠ çæ¡ä»¶ãåå³ããã äŸãã°ã è¶
é³æ³¢ãäœçšãããå Žåã¯ã æ¯ååãè©Šæ ã«æµžãããã æ¯ååãåãä»ããåããç¶å®¹åšã«è©Šæãå
¥ãããªã©ã㊠åŠçããããšãå¯èœã§ããã ãŸãé£ç¶åŠçã®å¯èœãªè£
眮ã䜿çšããããš ãã§ãã åœè©²åéã§ç¥ãããè£
眮ã®äžããéžãã§é©å®å©çšããŠçšããã ãšãã§ããã ããã«çŽ°èèãæå·ãããã«ã¯ã 浞éå§ã·ã§ãã¯æ³ã åçµ è解æ³ãªã©ãçšããããšãå¯èœã§ããã
ãŸãã 枬å®å€ããçŽæ¥çŽ°èçåçãæ±ããããšãã§ããªãå Žåã¯ã å¿
èŠã«å¿ããŠã åŠçæ¡ä»¶ããšã«æ€éç·ãæ°ãã«äœæãã 枬å®å€ãè£æ£ããã æ»çŽ°èã®æž¬å®ãè¡ã€ãåŸã®æž¬å®è©Šæäžã«ååšããç现èã®çŽ°èèãæ å·ãããåŠçãè¡ãã 现èãæ»æ»
ããããšã æ žé
žèå
æè²å€ããã£ãŠã® ç现èå
ã«ã䟵å
¥ãã æ žé
žãšçµåãèå
ãçºããã åŸã£ãŠã 枬å®è©Šæã ãã¯ãã£ãŠã®ç现èãçºããèå
ã®åã ãå¢åŒ·ãããèå
ãçºãããã ããšã«ãªãã ãã®å¢åŒ·ãããèå
ã®åŒ·åºŠ ïŒF t' ) ãèå
枬å®èšã«ãã 枬å®ããããšã«ããã 枬å®è©Šæäžã«ååšããå
šçŽ°èæ°ãå®éããããšã ã§ããã ãããŠå
šçŽ°èæ°ããæ»çŽ°èæ°ãæžããããšã«ããç现èæ°ãå® éããããšãã§ããã å
·äœçã«ã¯ F t=F t' â Fb' ããã³ F 1 = F t -F d = (F t' â FbïŒ ) äž (F d" âFb) ãšããèšç®åŒã«ã ãã å
šçŽ°èæ°ã«çžåœããèå
匷床 ïŒF t) ããã³ç现èæ°ã«çžåœããè å
匷床 ïŒF 1) ãããããæ±ãã ãããã®å€ããå
šçŽ°èæ°ããã³ç现è æ°å³ã¡çå现èæ°ãæ€éç·ãªã©ã«ãã€ãŠå®éããããšãã§ããã ãªãã Fb' ã¯çŽ°èæ¯æ§ãè©äŸ¡ãã¹ã察象ã å¹é€æ¶²ã æ žé
žæè²å€ããã³çŽ°èè ãæå·ããè¬å€ã«ç±æ¥ããããã¯ã°ã©ãŠã³ãã®èå
匷床ã§ããã 现èè ãæå·ããããã«ã çé¢æŽ»æ§å€ãäœçšãããå Žåã«ã¯ã Fb = Fb' ãš ãªãå Žåãå€ãã®ã§ã ãããã£ãå Žåã«ã¯ F 1 =F t' â Fd' ãšãã èšç®åŒã«ãã Fããæ±ããããšãã§ããã
åäžæ¡ä»¶ã®æž¬å®è©Šæãäœç¹ãçšæãã ãã®äžã®åæ°ã®è©Šæã«ã€ãåèš æ¹æ³ã§åèšæ»çŽ°èæ°ã枬å®ãã äžæ¹æ®ãã®åæ°ã®è©Šæã«æ žé
žèå
æè²å€ ãäœçšãããåŠçããã³çŽ°èèãæå·ãããåŠçãæœãã åèšæ¹æ³ã®å Ž åãšåæ§ã«å
šçŽ°èæ°ãæ±ããã ãã®ããã«ããŠæ±ããå
šçŽ°èæ°ããæ»çŽ° èæ°ãæžããããšã«ããçå现èæ°ã枬å®ããããšãã§ããã ãã®æ¹æ³ ã§ã¯æ»çŽ°èæ°ã®æž¬å®å·¥çšãšå
šçŽ°èæ°ã®æž¬å®å·¥çšãšã䞊è¡ããããšãå¯èœ ãªã®ã§å¹çã®ãã枬å®ãã§ããã ããããªããã å€ãã®è©Šæã«ã€ã枬å®
ãè¡ããªããã°ãªããªãããšã 枬å®èª€å·®ã倧ãããªããªã©ã®åé¡ç¹ãç ããå¯èœæ§ãããã äžæ¹ã åäžè©Šæã«ã€ããŠæ»çŽ°èæ°ã®æž¬å®ãè¡ã£ãåŸã å
šçŽ°èæ°ã®æž¬å®ãè¡ãå Žåã å
ã®æž¬å®å·¥çšãšåŸã®æž¬å®å·¥çšã®æéééã åé¡ãšãªãã 該æéééã¯æž¬å®ãã¹ã现èçš®ã æ žé
žèå
æè²å€ã 现èè ãæå·ããè¬å€ãªã©ã®åçš®æ¡ä»¶ã«ãã£ãŠç°ãªããã çæéãããã æ㟠ãã㯠2æé以å
ã§ããã ããã«æãŸããã¯äžæé以å
ã§ããã åŸã£ãŠã 枬å®ãã¹ã现èçš®ã æ žé
žèå
æè²å€ã 现èèãæå·ããè¬å€ãªã©ã®åçš® æ¡ä»¶ãèæ
®ããŠã ãããã®æ¹æ³ãã ãããã®æ¡ä»¶ã«ãã£ãšãé©ããæž¬å® æ³ã§ããããéžæããã®ãæãŸããã
现èçåçã¯å®éãããå
šçŽ°èæ°ããã³çå现èæ°ã®å€ããç®åºã§ã ãã ãŸãã æ»çŽ°èæ°ãæ®ã© 0ãšæšå®ãããå Žåã F 1 tãšãªãã®ã§ã æ žé
žèå
æè²å€ãšçŽ°èèãæå·ããè¬å€ãšãäžåºŠã«åæã«äœçšãããŠè å
匷床ã枬å®ãããšã äžåã®èå
枬å®ã ãã§å
šçŽ°èæ°å³ã¡çå现èæ°ã å®éã§ããã ãªãã å»è¬åã 蟲è¬ã å粧åã é£åãªã©ã§ã¯ã çå现èæ° ããã³çŽ°èçåçã®å€ã«ãã£ãŠã ãããã®ãããŒã现èæ¯æ§ãè©äŸ¡ãã å Žåãããã äŸãã°çå现èæ°ãã 5 0 %ã®çŽ°èãæ»çŽ°èãšãªãè¬å€ç ã®æ¿åºŠ I C 5 Dãæ±ããå Žåããããã æ¬çºæã®æ¹æ³ã«ããã°ã ããã㮠现èæ¯æ§ã簡䟿ãã€å¹ççã«è©äŸ¡ããããšãã§ããã
æ¬çºæã§ã¯ã çå现èæ°ãç®åºããããšãªãã çŽæ¥çŽ°èçåçãæž¬å® ããããšãå¯èœã§ããã
æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãäœçšãããåŠçãæœããæž¬å® è©Šæãçºããèå
ã®åŒ·åºŠãšã è©²æ žé
žèå
æè²å€ãäœçšãããåŠçãã㳠现èèãæå·ãããåŠçãæœãã枬å®è©Šæãçºããèå
ã®åŒ·åºŠãšããã ãã枬å®ãã第 1å·¥çš ïŒæ¬å·¥çšã¯å枬å®åã«æœãããåã
ã®åŠçãå«ãïŒ äžŠã³ã«äž¡åŒ·åºŠã察æ¯ãã第 2å·¥çšããæãäžé£ã®å·¥çšã«ãããåæäœã çµã¿åãããŠã·ã¹ãã åãã çå现èæ°ãŸãã¯çŽ°èã®çåçãåºåãã
æ©èœãæãã枬å®åšã«ããæ¬çºæãè¡ãããšãã§ããã 該枬å®åšã«ãã ãŠã¯ã åèšã·ã¹ãã 第 1å·¥çšå枬å®åã«æœãããåã
ã®åŠçãè¡ãã¹ã äºãæ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãšçŽ°æå
èãæå·ããè¬å€ãšã ã»ã åããã·ã¹ãã ãå©çšããŠæ¬çºæãè¡ãã®ãæãŸããã ãã®ãã㪠枬å®åšã«ã¯ã çå现èæ°æž¬å®çšãã ãããã³ ZãŸãã¯çŽ°èçåç枬å®çš ãã åãé©çšã§ããã®ã§ã æ¬çºæã®çå现èæ°ããã³ ZãŸãã¯çŽ°èçå çã®æž¬å®ãå¹ççã«è¡ãããšãã§ããã æ¬çºæã®æž¬å®ãèªåçã«è¡ãè£
眮ãšããŠã¯ã äŸãã°ç¬¬ 1å³ã«ç€ºããè£
眮ã第 2å³ã«ç€ºããè£
眮ãæãã ããã ãªã該è£
眮ã§ã¯ã çå现èæ°æž¬å®è£
眮ãšè¡šçŸããŠãããã 现èç åç枬å®è£
眮ã ãããã¯çå现èæ°ããã³/ãŸãã¯çŽ°èçåç枬å®è£
眮 ãšãããã®ãšç解ããŠãããã æ¬æ现æžããã³è«æ±ã®ç¯å²ã«ãããŠã¯è©² è£
眮ã¯åºãæå³ã§ç解ãããã¹ãã§ããã
第 1å³ã«ãããŠã åäžè©Šæã«ã€ããŠæ»çŽ°èæ°ã®æž¬å®ãè¡ã£ãåŸã å
š 现èæ°ã®æž¬å®ãè¡ãæ¹æ³ã§æ¬çºæãè¡ãå Žåã®çå现èæ°æž¬å®è£
眮ã®äž äŸã瀺ããŠããã ãã®ããã«è©²è£
眮ã¯ã ãã®è£
眮å
ã«çµã¿èŸŒãŸããåå
èå
å
床èšãããªããã®ã§ã ããã§ã¯æªæè£
眮ä»ã枬å®ãã¥ã¹ã ã ïŒ6 ) ã å±å
åŽåå
åš ïŒ 1 4 ) ã èå
åå
åš ïŒ 1 5 ) ã å
æº ïŒ 1 0 ) ã ã¬ã³ãº ( 5ã 9ããã³ 1 1 ) ã åå
æ¿ ïŒ4ããã³ 1 2 ) ããã³å
é»ååå¢ç®¡ ( 1 3 ) ã«ãã£ãŠæ§æãããŠããã å³äžã® 1ã¯çŽ°èèãæå·ããè¬å€ã 3ã¯æ»çŽ°èã®ã¿ãæè²ããæ žé
žæè²å€ã瀺ãã ããããã®è¬å€ã¯è£
çœ®äž ã®ã¿ã³ã¯ãŸãã¯è±çå¯èœãªå®¹åšå
ã«ã»ã åãããŠããã ãããã¿ã³ã¯ãŸ ãã¯è±çå¯èœãªå®¹åšå
ã«ã»ã ããããè¬å€ã¯ã è¬å€æ³šå
¥åš ïŒ2 ) ã«ãã æªæè£
眮ä»ã枬å®ãã¥ã¹ã ã ïŒ6 ) äžã«æ³šå
¥ããããšãã§ããã è£
眮㫠ã¯é©å®å¶åŸ¡ã®ããã®ãã«ãããã³ã ïŒå³ç€ºãããŠããªãïŒ ãåãä»ãã ããŠããã ãŸãã å¿
èŠã«å¿ããŠæŽæµãã³ãã æ液ãã³ãã åæ¿ããã«ãã æªæçšãšã¢ãŒãã³ãã ããºã«ãªã©ãåãä»ããããŠããããšãã§ããã
ãŸãã å³äžã® 7ã¯ã ã¢ããã°ä¿¡å·ãããžã¿ã«ä¿¡å·ã«å€æããè£
眮ã瀺ãã 8ã¯å¶åŸ¡ã·ã¹ãã ã§ããã ãŸã枬å®ãã¥ã¹ã å ïŒ6 ) ã¯ã å¿
èŠã«å¿ã㊠é£ç¶çã«ç§»åãããããã«ããã è€æ°ã®ãã¥ã¹ã åã«ã€ããŠèªåçã«æž¬ å®ãè¡ããããã«ããŠããããšãã§ããã 枬å®ãã¥ã¹ã ã ïŒ6 ) ã¯ã æ 枩槜ã«ä¿æãããããã«ãªã£ãŠããããšãã§ããã ããã«æž¬å®ãã¥ã¹ã ã ïŒ6 ) ãåºå®ãã è¬å€æ³šå
¥åšããã³åå
èå
å
床èšãå¿
èŠã«å¿ããŠé£ ç¶çã«ç§»åãããããã«ããŠã èªåçã«æž¬å®ãè¡ãããšãã§ããã
第 2å³ã«ãããŠã åäžæ¡ä»¶ã®æž¬å®è©Šæãäœç¹ãçšæãã ãã®äžã®åæ° ã®è©Šæã«ã€ãåèšæ¹æ³ã§åèšæ»çŽ°èæ°ã枬å®ãã äžæ¹æ®ãã®åæ°ã®è©Šæ ã«æ žé
žèå
æè²å€ãäœçšãããåŠçããã³çŽ°èèãæå·ãããåŠçãæœ ãã åèšæ¹æ³ã®å Žåãšåæ§ã«æ»çŽ°èæ°ãæ±ããå Žåã®è©Šæã«ã€ããŠæ»çŽ° èæ°ã®æž¬å®ãè¡ã€ãåŸã å
šçŽ°èæ°ã®æž¬å®ãè¡ãæ¹æ³ã§æ¬çºæãè¡ãå Žå ã®çå现èæ°æž¬å®è£
眮ã®äžäŸã瀺ããŠããã ãã®ããã«è©²è£
眮ã¯ã ãã® è£
眮å
ã«çµã¿èŸŒãŸããåå
èå
å
床èšãããªããã®ã§ã ããã§ã¯ãã¬ãŒ ãæªæåšä»ã 9 6ãŠã§ã«ãã€ã¯å£ãã¬ãŒã ïŒ5 ) ã å±å
åŽåå
åš ïŒ1 5 ) ã èå
åå
åš ïŒ1 6 ) ã å
æº ïŒ1 1 ) ã ã¬ã³ãº ïŒ7ã 1 0ããã³ 1 2 ) ã åå
æ¿ ïŒ6ããã³ 1 3 ) ããã³å
é»ååå¢ç®¡ ïŒ1 4 ) ã«ãã£ãŠæ§æãã ãŠããã å³äžã® 1ã¯çŽ°èåžéæžæ¿æ¶²ã§ããã è£
眮äžã®ã¿ã³ã¯ãŸãã¯è±ç å¯èœãªå®¹åšå
ã«ã»ã åãããŠããã åäžæ¿åºŠã®æžæ¿æ¶²ãã¿ã³ã¯ããå㥠ãšã«ãžäŸçµŠããããã«ã ã¿ã³ã¯ãŸãã¯è±çå¯èœãªå®¹åšå
ã«ã¯æªæåšãå ãä»ããããŠããã ãŸãã 2ã¯çŽ°èèãæå·ããè¬å€ã 4ã¯æ»çŽ°èã®ã¿ ãæè²ããæ žé
žæè²å€ã§ããã ããããã®è¬å€ã¯è£
眮äžã®å€ã³ã¯ãŸã㯠è±çå¯èœãªå®¹åšå
ã«ã»ã åãããŠããã ãããã¿ã³ã¯ãŸãã¯è±çå¯èœãª 容åšå
ã«ã»ã åãããæžæ¿æ¶²ãŸãã¯è¬å€ã¯ã åæ³šåš ïŒ3 ) ã«ãã£ãŠãã¬ãŒ ãæªæåšä»ã 9 6ãŠã§ã«ãã€ã¯å£ãã¬ãŒã ïŒ5 ) äžã®åã¥ãšã«ãžå泚ã ãããšãã§ããã åæ³šåš ïŒ3 ) ã®å
端éšåã«ã¯ãã€ã¹ããŒã¶ãã«ããã
ãŸãã¯ããºã«ãè£
çãããŠããã å¿
èŠã«å¿ããŠãããã¯äº€æãŸãã¯æŽæµ ãå¯èœã§ããã ãŸãåæ³šåš ïŒ3) ã®å
端éšåã¯åå²ããŠããŠãããã è€ æ°ã®è©Šæã¥ãšã«ã«åæã«è¬å€ãå泚ããããšãå¯èœã§ããã ãŸãã å³äž ã® 8ã¯ã ã¢ããã°ä¿¡å·ãããžã¿ã«ä¿¡å·ã«å€æããè£
眮ã§ããã 9ã¯å¶åŸ¡ ã·ã¹ãã ã§ããã 該ãã€ã¯ããã¬ãŒå ïŒ5) ã¯ã å¿
èŠã«å¿ããŠé£ç¶ç㫠移åãããããã«ããã è€æ°ã®ãã€ã¯ããã¬ãŒãã«ã€ããŠèªåçã«æž¬å® å <è¡ããããã«ããŠããããšãã§ããã ããã«è©²ãã€ã¯ããã¬ãŒããåº å®ãã åæ³šåš ïŒ3) ããã³åå
èå
å
床èšãå¿
èŠã«å¿ããŠé£ç¶çã«ç§»å ãããããã«ããŠã èªåçã«æž¬å®ãè¡ãããšãã§ããã åäžè©Šæã«ã€ããŠæ»çŽ°èæ°ã®æž¬å®ãè¡ã€ãåŸã å
šçŽ°èæ°ã®æž¬å®ãè¡ã æ¹æ³ã§æ¬çºæãè¡ãå Žåã«ã¯ã 第 1å³ã«ç€ºããè£
眮ãçš ããŠæž¬å®ãè¡ã ãšå¹ççã§ããã ãã®è£
眮ã®äœ¿çšæ¹æ³ã®äžäŸã以äžã«ç€ºãã
ã1ã å¹é€æ¶²äžã®çŽ°èãªã©ã®æž¬å®è©Šæãã æªæåšãã»ã åããã枬å®çš ãã¥ãã ã ïŒ6) ã«ã»ã ããã æªæããã ãŸãã æ»çŽ°èã®ã¿ãæè²ãã æ žé
žæè²å€ ïŒ1 ) ããã³çŽ°èèãæå·ããè¬å€ ïŒ3) ã¯äºãè£
眮äžã®ã¿ ã³ã¯å
ã«ã»ã ãããŠããã
ã2ã æ»çŽ°èã®ã¿ãæè²ããæ žé
žæè²å€ ïŒ1 ) ãè¬å€æ³šå
¥åš ïŒ2) ã«ã〠ãŠã 枬å®è©Šæãã»ã åããã枬å®çšãã¥ã¹ã ã ïŒ6) ã«æ³šå
¥ã枬å®è©Šæ ãæè²ããã ãã®åŸã ãã®ãã®ãçºããèå
ã®åŒ·åºŠãåå
èå
å
床èšã« ãŠæž¬å®ããã 枬å®çµæã¯ã¢ããã°ä¿¡å·ããããžã¿ã«ä¿¡å·ã«å€æããã å¶ åŸ¡ã·ã¹ãã ïŒ8) ã«éãããã ãªãã æ»çŽ°èã®ã¿ãæè²ããæ žé
žæè²å€
(1) ã®äœ¿çšéã¯ã èå
匷床枬å®ã®å¶åŸ¡ã·ã¹ãã ïŒ8) ãšé£åããŠèªå çã«å¶åŸ¡ãããã
ã3ã ã2ã ã®æž¬å®çµäºåŸã®æž¬å®ãã¥ã¹ã å ïŒ6) ã«ã¯ã 现èèãæå· ããè¬å€ ïŒ 1 ) ãè¬å€æ³šå
¥åš ïŒ2) ã«ãã£ãŠæ³šå
¥ããã 枬å®è©Šæäžã®å
š
ãŠã®çŽ°èãæ»çŽ°èãšãããã ãã®åŸã ãã®ãã®ãçºããèå
ã®åŒ·åºŠãå å
èå
å
床èšã«ãŠæž¬å®ããã 枬å®çµæã¯ã¢ãå£ã°ä¿¡å·ããããžã¿ã«ä¿¡å· ã«å€æããã å¶åŸ¡ã·ã¹ãã ïŒ8 ) ã«éããã ã2ã ã®æž¬å®çµæãšå¯Ÿæ¯ã ãŠã 现èçåçã枬å®ãããã ãŸãå¿
èŠã«å¿ããŠçŽ°èæ°ãæ¢ç¥ã§ããäž ã€é©åœãªçŽ°èæ°ã§ããããã€ãã®è©Šæã«ã€ããŠåèšã®æž¬å®ãè¡ãã æ¬è£
眮ã«æ€éç·ãäžãã 现èæ°ãäžæãªè©Šæã«ã€ããŠçå现èæ°çã枬å®ã ãããšãã§ããã
åäžæ¡ä»¶ã®æž¬å®è©Šæãäœç¹ãçšæãã ãã®äžã®åæ°ã®è©Šæã«ã€ãåèš æ¹æ³ã§åèšæ»çŽ°èæ°ã枬å®ãã äžæ¹æ®ãã®åæ°ã®è©Šæã«æ žé
žèå
æè²å€ ãäœçšãããåŠçããã³çŽ°èèãæå·ãããåŠçãæœãã åèšæ¹æ³ã®å Ž åãšåæ§ã«å
šçŽ°èæ°ãæ±ããå Žåã«ã¯ã 第 2å³ã«ç€ºããè£
眮ãçšããŠæž¬ å®ãè¡ããšå¹ççã§ããã ãã®è£
眮ã®äœ¿çšæ¹æ³ã®äžäŸã以äžã«ç€ºãã ã 1ã åäžæ¡ä»¶ã®æž¬å®è©Šæãçšæããããã 枬å®è©Šæã现èåžéæžæ¿æ¶² ( 1 ) ãšããŠåæ³šåš ïŒ3 ) ã«ããã ãã¬ãŒãæªæåšä»ã 9 6ãŠã§ã«ã㣠ã¯ããã¬ãŒã ïŒ5 ) ã®åã
ã®ã¥ãšã«ã«å泚ããã å泚åŸã ãã€ã¯ããã¬ãŒ ãããã¬ãŒãæªæåšã§æªæããã ãŸãã æ»çŽ°èã®ã¿ãæè²ããæ žé
žæè² å€ ïŒ2 ) ããã³çŽ°èèãæå·ããè¬å€ ïŒ4 ) ã¯äºãè£
眮äžã®ã¿ã³ã¯å
ã« ã»ã ãããŠããã
ã2ã 现èã®ã¿ãæè²ããæ žé
žæè²å€ ïŒ2 ) ãå泚åšã«ãã£ãŠã 枬å®è©Š æãã»ã åããã 9 6ãŠã§ã«ãã€ã¯å£ãã¬ãŒå ïŒ5 ) ã«å泚ã枬å®è©Šæ ãæè²ããã ãã®åŸã åã
ã®ã¥ãšã«äžã®è©Šæãçºããèå
ã®åŒ·åºŠãåå
èå
å
床èšã«ãŠæž¬å®ããã 枬å®çµæã¯ã¢ãå£ã°ä¿¡å·ããããžå€ã«ä¿¡å·ã« å€æããã å¶åŸ¡ã·ã¹ãã ïŒ9 ) ã«éãããã ãªãã æ»çŽ°èã®ã¿ãæè²ã ãæ žé
žæè²å€ ïŒ4 ) ã®äœ¿çšéã¯ã èå
匷床枬å®ã®å¶åŸ¡ã·ã¹ãã ïŒ9 ) ãš é£åããŠèªåçã«å¶åŸ¡ãããã ãªãã å泚åšã«ã¯è¬å€ããšã«å¥ã
ã®å泚 管ãã€ããŠããã 1åã®æäœã§è€æ°ã®ã¥ãšã«ã«è¬å€ãå泚ããããšãã§
ããã
ã3ã 现èèãæå·ããè¬å€ ïŒ2 ) ããã³æ»çŽ°èã®ã¿ãæè²ããæ žé
žæ è²å€ ïŒ4 ) ãããããå泚åšã«ãã£ãŠã ã2ã ã®æž¬å®ã§äœ¿çšãããã®ãš åäžæ¡ä»¶ã®æž¬å®è©Šæãã»ã åããã 9 6ãŠã§ã«ãã€ã¯å£ãã¬ãŒã ïŒ5 ) ã«å泚ãã 枬å®è©Šæäžã®çŽ°èãå
šãŠæ»çŽ°èãšãããšåæã«æè²ããã ã ã®åŸã åã
ã®ã¥ãšã«äžã®è©Šæãçºããèå
ã®åŒ·åºŠãåå
èå
å
床èšã«ãŠ 枬å®ããã 枬å®çµæã¯ã¢ããã°ä¿¡å·ããããžã¿ã«ä¿¡å·ã«å€æããã å¶åŸ¡ ã·ã¹ãã ïŒ9 ) ã«éãããã ãªãã 现èèãæå·ããè¬å€ ïŒ2 ) ããã³ æ»çŽ°èã®ã¿ãæè²ããæ žé
žæè²å€ ïŒ4 ) ã®äœ¿çšéã¯ã èå
匷床枬å®ã®å¶ 埡ã·ã¹ãã ïŒ9 ) ãšé£åããŠèªåçã«å¶åŸ¡ãããã 枬å®çµæã¯ã¢ããã° ä¿¡å·ããããžã¿ã«ä¿¡å·ã«å€æããã å¶åŸ¡ã·ã¹ãã ïŒ9 ) ã«éããã ã2ã ã®æž¬å®çµæãšå¯Ÿæ¯ããŠã 现èçåçã枬å®ãããã ãŸãå¿
èŠã«å¿ããŠçŽ° èæ°ãæ¢ç¥ã§ããäžã€é©åœãªçŽ°èæ°ã§ããããã€ãã®è©Šæã«ã€ããŠåèš ã®æž¬å®ãè¡ãã æ¬è£
眮ã«æ€éç·ãäžãã 现èæ°ãäžæãªè©Šæã«ã€ããŠç å现èæ°çã枬å®ããããšãã§ããã ãã®ããã«æ¬çºæã«åŸãã°ã ïŒa ) æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æ è²å€ã枬å®å¯Ÿè±¡è©Šæã«äŸçµŠããæ段ã ïŒb ) è©²æ žé
žèå
æè²å€ãäœçšã ãã枬å®å¯Ÿè±¡è©Šæãçºããèå
ã®åŒ·åºŠã枬å®ããæ段ã ïŒc ) 现èèã æå·ãããããšãå¯èœã«ããæ段ã ïŒd ) æ»çŽ°èã®ã¿ãæè²ããæ žé
žè å
æè²å€ãäœçšããäžã€çŽ°èèãæå·ãããåŠçãæœãã枬å®å¯Ÿè±¡è©Šæ ãçºããèå
ã®åŒ·åºŠã枬å®ããæ段ãã å°ãªããšãåããŠããäžã€æž¬å® ãããåã
ã®èå
ã®åŒ·åºŠã«ã€ãäžèš ïŒb ) ãšäžèš ïŒd ) ã®äž¡åŒ·åºŠãå¯Ÿæ¯ ããæ段ãåããŠããããšãç¹åŸŽãšããçå现èæ°ããã³/ãŸãã¯çŽ°è çåçã®æž¬å®è£
眮ãæäŸããããã ããããè£
眮ã®ãã¡ã®åæ§æèŠçŽ ã¯ã èªååãããå
ç«æž¬å®è£
眮ã èªååãããçååŠç枬å®è£
眮ãªã©ã®åé
ã§ç¥ããããã®ã®ãã¡ããéžãã§é©çšããŠäœ¿çšããããšãã§ãããã ã ããã¯å¿
èŠã«å¿ããŠé©å®æ¹å€ãå ããŠäœ¿çšããããšãã§ããã 奜ãŸãã ã¯ããã°ã©ã ãããã³ã³ãã¥ãŒã¿äžã äŸãã°ãã€ã¯ãã³ã³ãã¥ãŒã¿äžã« ãã£ãŠã äžèš ïŒa ) æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ã枬å®å¯Ÿè±¡è©Š æã«äŸçµŠããæ段ã ïŒb ) è©²æ žé
žèå
æè²å€ãäœçšããã枬å®å¯Ÿè±¡è©Šæ ãçºããèå
ã®åŒ·åºŠã枬å®ããæ段ã ïŒc ) 现èèãæå·ãããããšã å¯èœã«ããæ段ã ïŒd ) æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãäœçšã ãäžã€çŽ°èèãæå·ãããåŠçãæœãã枬å®å¯Ÿè±¡è©Šæãçºããèå
ã®åŒ· 床ã枬å®ããæ段ã åã³æž¬å®ãããåã
ã®èå
ã®åŒ·åºŠã«ã€ãäžèš ïŒb ) ãšäžèš ïŒd ) ã®äž¡åŒ·åºŠã察æ¯ããæ段ã®ããããäžãããã¯ãã®å
ã®è€ æ°ã ãããã¯å
šéšãå¶åŸ¡ãããŠãããã®ãæããããã
ãªãã æ¬çºæã®çå现èæ°ããã³/ãŸãã¯çŽ°èçåçã®æž¬å®æ³äžŠã³ã« çå现èæ°ããã³ ZãŸãã¯çŽ°èçåç枬å®çšãã åã«ãããŠã¯ã åèšã ãçš®ã
ã®æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãšåèšããçš®ã
ã®çŽ°èè ãæå·ããè¬å€ãšãããããçžäºã«çµã¿åãããŠäœ¿çšããããšãã§ãã å'ã åèšããçš®ã
ã®æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãšåèšããçš®ã
ã®çé¢æŽ»æ§å€ãšãçµã¿åãããŠäœ¿çšããã®ãæãŸããã
ãŸãã æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãšåèšããçš®ã
ã®çé¢æŽ» æ§å€ãå¿
èŠã«å¿ããŠäºãæ··åãããã®ã䜿çšããããšãã§ããã
ããã«ã åèšç¬¬ 1å³ãŸãã¯ç¬¬ 2å³ã§ç€ºãããçå现èæ°æž¬å®è£
眮 ïŒã ã ãã¯çå现èæ°ããã³ããŸãã¯çŽ°èçåç枬å®è£
çœ®ïŒ ã«å¯Ÿå¿ããåèš çå现èæ°ããã³ ZãŸãã¯çŽ°èçåç枬å®çšãã ãã®æãŸãã圢æ
ã®äžã€ ãšããŠã æ»çŽ°èã®ã¿ãæè²ããæ žé
žæè²å€ããã³çŽ°èèãæå·ããè¬å€ ã®ãããããã 該çå现èæ°æž¬å®è£
眮ã®è±çå¯èœãªå®¹åšã«äºãå
å¡¡ãã ãŠãããã®ãæããããã ãã®å Žåã 該æè²å€ã 該è¬å€ã¯ããããå¥ã
ã®è©²è±çå¯èœãªå®¹åšã«å
å¡«ããããã å¿
èŠã«å¿ããŠåäžã®è©²è±çå¯èœãª
容åšã«å
å¡¡ãããŠãããã å®æœäŸ
æ¬çºæããã詳ããè¿°ã¹ãããã 以äžã«å®æœäŸãèšèŒãããã ããã ã¯æ¬çºæãéå®ãããã®ã§ã¯ãªãã æ¬çºæã¯å®æœäŸã«éå®ãããããšç¡ ãæ§ã
ãªæ
æ§ãå«ãŸããããšã¯ç解ãããã¹ãã§ããã
å®æœäŸ 1 (现èçåçã®æž¬å®ïŒ
( 1 ) æ¹æ³ã çµæ
â MOLTâ 4现è ïŒã ãæ¥æ§ãªã³ãèœçæ§çœè¡ç
现èïŒå€§éªå€§åŠåŸ®ç ç©ç 究æããå
¥æïŒ ã 37ãŠã 5%äºé
žåççŽ ã 飜åæ°Žèžæ°æ¡ä»¶äžã ã·ã£ãŒã¬äžã§å¹é€ããã å¹é€æ¶²ã¯ 1 0 %çèå
è¡æž
ãå«ã RPM I液
(G I BCO瀟補ã No. 31800 - 071 ïŒä»¥äžå¹é€æ¶²ãšèšèŒããïŒ ã䜿çšããã
â¡çŽ°èæ¿åºŠãé«å¯åºŠã«ãªã€ãæé©å®å¹é€æ¶²ã亀æããã·ã£äžã¬äžã®è©Šæ (è¯ãå¹é€æ¡ä»¶äžã®è©ŠæïŒ ãšã å¹é€æ¶²ã®äº€æãªãã«å¹é€ãè¡ã£ãã·ã€ãŒ ã¬äžã®è©Šæ 2ç¹ ïŒæªãå¹é€æ¡ä»¶äž ïŒ1) ããã³ ïŒ2) ã®è©ŠæïŒ ã现èç åç枬å®çšè©Šæãšããã
â¢åè©Šæãã·ã£ãŒã¬ããæ¡åãã èå
枬å®çšãã¥ã¹ã ãã«å
¥ãã å転æ æåã§æªæããªãã以äžã®æž¬å®ãè¡ã£ãã ãªãã èå
匷床ã®æž¬å®ã¯ã å å
èå
å
åºŠèš ïŒæ¥ç« Fâ 4000åïŒ ã«ãŠã å±èµ·æ³¢é· 420 nmã èå
æŸå°æ³¢é· 460 nmã®æž¬å®æ¡ä»¶äžã§è¡ã£ãã
â£å
ãã POâ PROâ l I od i de (åååïŒ M o 1 e c u 1 a r P rob e s瀟補ã No. Pâ 358 1 ) ãæ·»å ã ïŒæçµæ¿åºŠ 2. 5 u M) . F d' ã枬å®ããã åŒãç¶ãã åã枬å®ç³»ã«ã㪠ãã³ Xâ 100
(åååïŒ P I ERCE CHEM I C A Lç€Ÿè£œïŒ ãæ·»å ã ïŒæçµæ¿åºŠ 0. 05%) ã F t' ã枬å®ãã åè¿°ã®èšç®åŒãã现èçåçãæ±ãçµ
æãè¡š 1ã«ç€ºããã
â€æ¯èŒã®ããã åè©Šæã«ã€ãããªãã³ãã«ãŒæè²æ³ã«ãã现èçåçã é¡åŸ®é¡äžã§æž¬å®ãã çµæãè¡š 1ã«ç€ºããã ããªãã³ãã«äžæè²æ³ã«ãã 枬å®å€ã¯ã å®æœäŸ 1ã®æž¬å®å€ãšã»ãŒåäžã®å€ã瀺ãã æ¬çºæã«ããæ¹æ³ ã¯çŽ°èçåçã®æž¬å®ã«ååé©çšã§ããããšãå€æããã ãªãã ãã®æž¬å® ã¯ç¬¬ 1å³ã«ç€ºããè£
眮ã«ããèªåã£ãããŠãè¡ãããšãå¯èœã§ããã è¡š 1. 现èçåç
å®æœäŸ 2 (æ žé
žæè²å€ãšçŽ°èãšã®åå¿ã®å®éæ§ïŒ
( 1 ) æ¹æ³ããã³çµæ
â MOLTâ 4ã HL- 6 0 (ã ãå骚é«æ§çœè¡ç
现èïŒ ã U 9 3 7 ( ããçµç¹çæ§ãªã³ãè
«çŽ°èïŒ ã HTâ 1 0 8 0 (ã ãç¹ç¶èè
«çŽ°èïŒ ã 枬å®çšè©ŠæãšããŠäœ¿çšããã MOLTâ 4以å€ã¯ã 倧æ¥æ¬è£œè¬ããå
¥æ ããã
â¡æž¬å®çšè©Šæã®çŽ°èæ¿åºŠãå¹é€æ¶²ã§ 2åãã€åžéããŠã 现èåžéæžæ¿æ¶² ãäœè£œãã 9 6ã¥ãšã«ã®ãã€ã¯ããã¬ãŒåã®åã¥ã±ã«ã« 1 8 0ã 1ã〠å泚ããã
â¢åã¥ã±ã«ã« 1 0 w 1ã〠POâ PROâ 1 I o d i d e (åååïŒ
ãæ·»å ã ïŒæçµæ¿åºŠ 2. 5 M) ã æŽã«åã¥ãšã«ã« 1 0 1ãã€ã㪠ã ã³ Xâ 1 0 0 (åååïŒ ãæ·»å ã ïŒæçµæ¿åºŠ 0. 0 5 %) , ãã¬ãŒåæª æåšã«ãŠçŽ 3 0ç§éæªæåŸã èå
枬å®ãè¡ãã çµæã第 3å³ããã³ç¬¬ 4 å³ã«ç€ºããã
第 3å³ã¯ã æµ®éæ§çŽ°èã®çŽ°èæ°ãšèå
匷床ãšã®éã«æ¯äŸé¢ä¿ãããã ãšã瀺ããŠããã HLâ 6 0ããã³ Uâ 9 3 7ã¯ã 现èæ° 1. 2 5 x 1 04 ã4 X 1 05 åã®ç¯å²å
ã§çŽ°èæ°ãšèå
匷床ãšã®éã«æ¯äŸé¢ä¿ã ããã ãŸãã MOLTâ 4ã¯ã 现èæ° 1. 2 5 x l (T ã2 x l 05 å ã®ç¯å²å
ã§çŽ°èæ°ãšèå
匷床ãšã®éã«æ¯äŸé¢ä¿ãããã
第 4å³ã¯ã æ¥çæ§çŽ°èã®çŽ°èæ°ãšèå
匷床ãšã®éã«æ¯äŸé¢ä¿ãããã ãšã瀺ããŠããã Î΀â 1 0 8 0ã¯ã 现èæ° 3 0 0ã 1 X 1 05 åã®ç¯ å²å
ã§çŽ°èæ°ãšèå
匷床ãšã®éã«æ¯äŸé¢ä¿ãããã
ãªãã èå
匷床ã®æž¬å®ã¯å±èµ·æ³¢é· 4 2 0 nmã èå
æŸå°æ³¢é· 4 6 0 n m ã®æž¬å®æ¡ä»¶äžã§ã MTPâ 3 2ã³ãããã€ã¯ããã¬ãŒããªãŒãäž ïŒã³ã ãé»æ°ç€Ÿè£œïŒ ã«ãŠè¡ã£ãã ãªãã ãã®æž¬å®ã¯ç¬¬ 2å³ã«ç€ºããè£
眮ã«ãã èªååããŠãè¡ãããšãå¯èœã§ããã
(2) èå¯
第 3å³ããã³ç¬¬ 4å³ã®çµæããã æµ®éæ§çŽ°èãšæ¥çæ§çŽ°èãšã¯ç°ãªã€ ã枬å®ç¯å²ã§èå
匷床ã枬å®ããå¿
èŠããããã®ã®ã 现èæ°ãšèå
匷床 ãšã®éã«ã¯æ¯äŸé¢ä¿ãããããã æ¬æ¹æ³ã«ããæ£ç¢ºã«çå现èæ°ãæž¬å® ã§ããããšãå€æããã å®æœäŸ 3 (è¬å€ã«ãã现èæ¯æ§ã®è©äŸ¡ïŒ
(1 ) æ¹æ³ããã³çµæ
â æçå€ã§ããã〠ããã€ã·ã³ C (ååé±é
µå·¥æ¥è£œïŒ ãå¹é€æ¶²ã«ãŠåžé ãã 9 6ã¥ã±ã«ã®ãã€ã¯ããã¬ãŒåã«åã¥ã±ã«åœãã 5 0 1ãã€å泚
ããã
â¡ç¶ããŠã MOLTâ 4现èãåã¥ã±ã«åœãã 3 X 1 0 å/ 1 5 0ã 1 ãã€å泚ããã
â¢åã¥ãšã«ã 3 7°Cã 5 %çé
žã¬ã¹ã 飜åæ°Žèžæ°æ¡ä»¶äžã§ 2æ¥éå¹é€ãã 以äžã®æž¬å®ãè¡ã£ãã å°ã èå
枬å®ã¯ MTPâ 3 2èå
枬å®åš ïŒã³ãã é»æ°ç€Ÿè£œïŒ ã䜿çšããã
â£åã¥ã±ã«ã« 1 0ã 1ã〠POâ PROâ 1 I o d i d e (åååïŒ ãæ·»å ã ïŒæçµæ¿åºŠ 2. 5 ιΠã ãã¬ãŒãæªæœåšã«ãŠçŽ 3 0ç§éæªæ åŸã èå
枬å®ãè¡ã F d' ãæ±ããã
â€æŽã«åã¥ã±ã«ã« 1 0 // 1ãã€ã㪠ãã³ Xâ 1 0 0 (åååïŒ ãæ·»å ã (æçµæ¿åºŠ 0. 0 5 %) ã ãã¬ãŒåæªæåšã«ãŠçŽ 3 0ç§éæªæåŸã èå
枬å®ãè¡ã F f ãæ±ããã
â¥åè¿°ããèšç®åŒã«ããã çå现èæ°ãšçŽ°èçåçãç®åºãã çµæã è¡š 2ã«ç€ºããã
âŠæ¯èŒã®ããã åè©Šæã«ã€ã C a n c e r R e s e a c hã 4 7å·»ã
9 3 6ã9 4 2é ã 1 9 8 7幎ãåèã« MTTã¢ãã»ã£æ³ã«ããçå现 èæ°ã枬å®ãã çµæãè¡š 2ã«ç€ºããã
ãŸãã æ¬çºæã«ããæ¹æ³ãš MTTã¢ãã»ã£æ³ã«ããçå现èæ°ã®æž¬å® ã¹ãããã®æŠç¥ãè¡š 3ã«ç€ºããã ãªãã æ¬çºæã«ããåèšã®æž¬å®ã¯ç¬¬ 2 å³ã«ç€ºããè£
眮ã«ããèªååããŠãè¡ãããšãå¯èœã§ããã
è¡š 2. ã〠ããã€ã·ã³ Cã®çŽ°èæ¯æ§è©äŸ¡ ã〠ããã€ã·ã³ Cæ·»å æ¿åºŠ ïŒ /g/ml) I C 5 0
100 10 1 0.1 0 ( g/ml)
(æ¬çºæã«ããæ¹æ³ïŒ
çå现èæ° ïŒïŒ
察ç
§ïŒ 3 24 63 76 100 2.2 现èçåç ïŒïŒ
) 29 87 100 99 98
(MTTæ³ïŒ
çå现èæ° ïŒïŒ
察ç
§ïŒ 3 34 95 120 100 5.5
è¡š 3. çå现èæ°ã®æž¬å®ã¹ãããã®æŠç¥ æ¬çºæã«ããæ¹æ³ MTTæ³
â PRO- 1(50 10 z 1/ ell 1å â é å¿åé¢ã 2000rpm 5å
â¡ãã€ã¯ Dã㬠-ãããã¶-æªæ 30ç§ â¡äžæž
æšãŠãã 2å
â¢èå
æž¬å® 420/460 30ç§ â¢ MTT(0.04%) 100 1 /we 11 1å
⣠TritonX- 100(1%) 10 l/well 1å ⣠37°Cã 5ŸC02 å¹é€ 3æé
â€ãã€ã¯ Dãã¬-ããããµ-æªæ 30ç§ â€ PBS 100// 1/well 1å
â¥èå
æž¬å® 420/460 30ç§ â¥é å¿ã 2000rpm 5å
âŠäžæž
æšãŠãã 2å
(DDMSO(100Ÿ) 150^1/ ell 1å
âšãã€ã¯ Dãã¬-ããããµ-æªæ 30ç§
â©åžå
åºŠæž¬å® 550nm 30ç§ åèšæèŠæé 4å åèšæèŠæé 3æé 20å
(2) èå¯
è¡š 2ã«ç€ºãåŠãã ã〠ããã€ã·ã³ Cã®çŽ°èæ¯æ§ã¯æ¬çºæã«ããæ¹æ³ã« ãããŠã I C 50å€ã 2. 2ãg/mlãšç®å®ãããã ãã®å€ã¯ã çŸåšè¬å€ ã®çŽ°èæ¯æ§è©äŸ¡ã«æãæ±çšãããŠãã MTTæ³ã«ãã枬å®å€ ïŒ5. 5 Ug/m\) ãšå¯Ÿæ¯ããã°ã / g/mlã®ãªãŒããŒã«æ¢ãŸãã åœè©²æè¡åéã§ã¯ 蚱容ãããæ°å€å·®ã§ãã£ãã 以äžã®ããšããã æ¬çºæã«ããæ¹æ³ã¯ã è¬ å€ã«ãã现èæ¯æ§è©äŸ¡ã«ååé©çšã§ããããšãå€æããã æŽã«æ¬çºæã¯ã åè¬å€æ¿åºŠã«ãããŠã®çŽ°èçåçãåæã«ç®å®å¯èœã§ããã è¬å¹ãè©äŸ¡ ããäžã§å€ãã®æ
å ±ãåŸããããšããå©ç¹ãããã äžæ¹ã 枬å®ã«èŠãã æéã¯è¡š 3ã®åŠãã æ¬çºæã«ããæ¹æ³ã§ã¯çŽ 5åã§å®äºãã æ¢åã® MT
Tæ³ ïŒ3æé 20åïŒ ãšæ¯ã¹é£èºçãªæéççž®ãå¯èœãšãªã£ãã ãŸãã æäœæ§ã®é¢ã«ãããŠãã æ¬çºæã«ããæ¹æ³ã¯ã é å¿åé¢ã æŽæµæäœã è² çŽ æº¶è§£ãäžèŠã§ããäžå±€ç°¡äŸ¿æ§ãå¢ããŠããã å®æœäŸ 4 (è¶
é³æ³¢ã«ãã现èèã®æå·ïŒ
( 1 ) æ¹æ³ã çµæ
â 5 X 1 06 åã® MOLTâ 4现èãå«ã 40 m 1ã®å¹é€æ¶²ã枬å®è©Šæ ãšããŠèå
枬å®çšãã¥ã¹ã åã«ååãã è¶
é³æ³¢ç Žç åš ïŒSON I CAT OR ULTRASON I C PROCESSOR, Mode l W - 225, Se r i a l No. G 6453 , 20 kHzïŒ HEAT S YSTEMSâ ULTRASON I C I NC. ) 㧠1 0ç§éåŠçãã
(ç Žç 匷床ã¬ãã« 3) ã
â¡è¶
é³æ³¢åŠçãæœãããã¥ã¹ã åäžã®è©Šæãã å転æªæåã§æªæããªã ã以äžã®æž¬å®ãè¡ã£ãã ãªãã èå
匷床ã®æž¬å®ã¯ã åå
èå
å
åºŠèš ïŒæ¥ç« Fâ 4000åïŒ ã«ãŠã å±èµ·æ³¢é· 420 n mã èå
æŸå°æ³¢é· 460 n m ã®æž¬å®æ¡ä»¶äžã§è¡ã£ãã â£å
ãã PO - PROâ 1 I od i d e (å
ååïŒ Mo l e c u l a r P r o b e s瀟補ã No. P- 3 5 8 1 ) ãæ·»å ã ïŒæçµæ¿åºŠ 2. 5 M) ã èå
匷床ã枬å®ãããšããã 4 1 0 (ããã¯ã°ã©ãŠã³ãã®èå
匷床㯠1 0) ã§ãã£ãã ç£æ¥äžã®å©çšå¯èœæ§
æ¬çºæã«ããã°ã æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãšçŽ°èèãæ å·ããè¬å€ã䜿çšããããšã«ããã å€æ€äœã®çå现èæ°ããã³/ãŸã㯠现èçåçã簡䟿ãã€è¿
éãªäžæ£ç¢ºã«æž¬å®ããããšãã§ãã å»è¬ã 蟲è¬ã å粧åã é£åãªã©ã®çŽ°èæ¯æ§ã®è©äŸ¡ãªã©ã«å©çšã§ããã ãŸããã®çŽ°èæ¯ æ§ã®è©äŸ¡ã簡䟿ãã€è¿
éã«è¡ãããšãã§ããã
Claims
1 . æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãäœçšããã枬å®è©Šæãçº ããèå
ã®åŒ·åºŠãšã è©²æ žé
žèå
æè²å€ãäœçšãããåŠçããã³çŽ°èèã æå·ãããåŠçãæœãã枬å®è©Šæãçºããèå
ã®åŒ·åºŠãšãåã
枬å®ãã 䞡匷床ã察æ¯ããããšãç¹åŸŽãšããçå现èæ°ããã³/ãŸãã¯çŽ°èçå çã®æž¬å®æ¹æ³ã
2 . (i ) 枬å®è©Šæã«å¯Ÿãæ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãäœçš ããã ãã®çµæçºããããèå
ã®åŒ·åºŠã枬å®ããåŸã ïŒi i)次ãã§ã ãã® è©Šæã®çŽ°èèãæå·ãããåŠçãæœãã 现èãæ»æ»
ãããããšã«ããå¢ åŒ·ãããèå
ã®åŒ·åºŠã枬å®ããããšãç¹åŸŽãšããè«æ±é
1èšèŒã®æž¬å®æ¹
3 . (i ) 枬å®è©Šæã«å¯Ÿãæ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãäœçš ããã ãã®ãã®ãçºããèå
ã®åŒ·åºŠã枬å®ãã ïŒi i)å¥ã®æž¬å®è©Šæã«å¯Ÿã è©²æ žé
žèå
æè²å€ãäœçšãããåŠçããã³çŽ°èèãæå·ãããåŠçãæœ ãã ãã®ãã®ãçºããèå
ã®åŒ·åºŠã枬å®ããããšãç¹åŸŽãšããè«æ±é
1 èšèŒã®æž¬å®æ¹æ³ã
4 . åèšæ žé
žèå
æè²å€ãã éœã£ã©ã³æ§æ žé
žèå
æè²å€ã§ããè«æ±é
1ã 3ã®ããããäžèšèŒã®æž¬å®æ¹æ³ã
5 . åèšæ žé
žèå
æè²å€ãã§ããžã¥ã ãã¢ãã€ãäžãŸãã¯æ»çŽ°èã® ã¿ãæè²ããã·ã¡ãã³ç³»æ žé
žèå
æè²å€ã§ããè«æ±é
1ã 4ã®ãããã äžèšèŒã®æž¬å®æ¹æ³ã
6 . 现èèãæå·ããè¬å€ãçšããŠçŽ°èèãæå·ãããè«æ±é
1ã 5 ã®ããããäžèšèŒã®æž¬å®æ¹æ³ã
7 . 现èèãæå·ããè¬å€ãçé¢æŽ»æ§å€ã§ããè«æ±é
6èšèŒã®æž¬å®æ¹
æ³ã
8. 现èèãæå·ããè¬å€ãããªã©ãã·ã§ãã¬ã³åéã£ã©ã³æ§çé¢æŽ» æ§å€ãŸãã¯ã¢ã«ã³äžã«åéã£ã©ã³æ§çé¢æŽ»æ§å€ã§ããè«æ±é
6ãŸã㯠7 èšèŒã®æž¬å®æ¹æ³ïŒ
9. æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãäœçšããã枬å®è©Šæãçº ããèå
ã®åŒ·åºŠãšã è©²æ žé
žèå
æè²å€ãäœçšãããåŠçããã³çŽ°èèã æå·ãããåŠçãæœãã枬å®è©Šæãçºããèå
ã®åŒ·åºŠãšãåã
枬å®ãã 䞡匷床ã察æ¯ããããšããæãäžé£ã®å·¥çšäžã®åã
ã®æäœãèªååãã ãè£
眮ã«ãŠè¡ãè«æ±é
1ã 8ã®ããããäžèšèŒã®æž¬å®æ¹æ³ã
1 0. æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãäœçšããã枬å®è©Šæã çºããèå
ã®åŒ·åºŠãšã 該æè²å€ããã³çŽ°èèãæå·ããè¬å€ãäœçšãã ã枬å®è©Šæãçºããèå
ã®åŒ·åºŠãšãåã
枬å®ãã 䞡匷床ã察æ¯ããããš ã§çå现èæ°ããã³ããŸãã¯çŽ°èçåçã®æž¬å®ãè¡ãããã®æ žé
žèå
æ è²å€ãšçŽ°èèãæå·ããè¬å€ãšãå«ãçå现èæ°ããã³ ZãŸãã¯çŽ°èç åç枬å®çšãã ãã
1 1. (a) æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ã枬å®å¯Ÿè±¡è©Šæã« äŸçµŠããæ段ã ïŒb) è©²æ žé
žèå
æè²å€ãäœçšããã枬å®å¯Ÿè±¡è©Šæãçº ããèå
ã®åŒ·åºŠã枬å®ããæ段ã ïŒc) 现èèãæå·ãããããšãå¯èœ ã«ããæ段ã ïŒd) æ»çŽ°èã®ã¿ãæè²ããæ žé
žèå
æè²å€ãäœçšããäž ã€çŽ°èèãæå·ãããåŠçãæœãã枬å®å¯Ÿè±¡è©Šæãçºããèå
ã®åŒ·åºŠã 枬å®ããæ段ãã å°ãªããšãåããŠããäžã€æž¬å®ãããåã
ã®^:å
ã®åŒ· 床ã«ã€ãäžèš ïŒb) ãšäžèš ïŒd) ã®äž¡åŒ·åºŠã察æ¯ããæ段ãåããŠãã ããšãç¹åŸŽãšããçå现èæ°ããã³/ãŸãã¯çŽ°èçåçã®æž¬å®è£
眮ã
1 2. (a) 现èèãæå·ããè¬å€ãä¿æããè£
眮ã ïŒb) æ»çŽ°èã® ã¿ãæè²ããæ žé
žèå
æè²å€ãä¿æããè£
眮ã ïŒc) äžèšè£
眮 ïŒa) ã ãã㯠ïŒb) ããã®è¬å€ã枬å®å¯Ÿè±¡è©Šæã«äŸçµŠããè¬å€æ³šå
¥åšã ïŒd)
枬å®å¯Ÿè±¡è©Šæãä¿æã§ãã容åšã åã³ ïŒe ) åå
èå
å
床èšãåããã ãšãç¹åŸŽãšããè«æ±é
1 1èšèŒã®æž¬å®è£
眮ã
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96943322A EP0881489A1 (en) | 1995-12-29 | 1996-12-27 | Method for determining viable cell count |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP35363595 | 1995-12-29 | ||
JP7/353635 | 1995-12-29 | ||
JP22747296 | 1996-08-08 | ||
JP8/227472 | 1996-08-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997024616A1 true WO1997024616A1 (fr) | 1997-07-10 |
Family
ID=26527691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1996/003842 WO1997024616A1 (fr) | 1995-12-29 | 1996-12-27 | Procede de determination du taux de viabilite de cellules |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020119438A1 (ja) |
EP (1) | EP0881489A1 (ja) |
WO (1) | WO1997024616A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011503579A (ja) * | 2007-11-09 | 2011-01-27 | ãžã§ã³ã¶ã€ã ã»ã³ãŒãã¬ãŒã·ã§ã³ | å¯Ÿç §çŽ°èã䜿çšããªã现èçåçã®æž¬å®æ¹æ³ |
JP4885448B2 (ja) * | 2002-05-03 | 2012-02-29 | ãã©ãã³ ã€ã¡ãŒãžã³ã° ãšãã» ã 㢠| æŸå°æ§å»è¬å補å€ïŒïœïœïœïœïœïœïœïœïœïœïœïœïœ ïœïœïœïœïœïœïœïœïœïœïœïœïœïœïœïœïœïœïŒ |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0008787D0 (en) * | 2000-04-10 | 2000-05-31 | Norsk Naeringsmiddelforskning | A method of cell detection |
WO2002008454A2 (en) | 2000-07-24 | 2002-01-31 | Genprime, Inc. | Method and device for viable and nonviable prokaryotic and eukaryotic cell quantitation |
US7833709B2 (en) | 2004-05-28 | 2010-11-16 | Wafergen, Inc. | Thermo-controllable chips for multiplex analyses |
KR20100019409A (ko) | 2007-01-22 | 2010-02-18 | ìšìŽíŒì , ìží¬. | ê³ íšìš íí ë°ìì ìí ì¥ì¹ ë° ë°©ë² |
US9631219B2 (en) * | 2010-02-24 | 2017-04-25 | Nalco Company | Metabolic rate indicator for cellular populations |
WO2013166336A1 (en) | 2012-05-02 | 2013-11-07 | Charles River Laboratories, Inc. | Viability staining method |
CN104755931B (zh) | 2012-05-02 | 2016-08-31 | æ¥å°æ¯æ²³å®éªå®€å ¬åž | çšäºæ£æµç»èæ ·åäžç掻ç»èçæ¹æ³ |
WO2013166338A2 (en) | 2012-05-02 | 2013-11-07 | Charles River Laboratories, Inc. | Cell capture system and use thereof |
TWI619809B (zh) * | 2012-08-24 | 2018-04-01 | äœç«¹è¡ä»œæéå ¬åž | 埮çç©ä¹æª¢æ¥æ¹æ³åå ¶è£çœ® |
US9274071B2 (en) | 2013-12-30 | 2016-03-01 | General Electric Company | Methods for assessing cell culture fluid by impedance spectra |
CN107407685B (zh) * | 2015-02-20 | 2021-08-03 | å®çç©å·¥çšïŒçŸåœ)æéå ¬åž | å¿«é粟确åé ãå¯è§åååæå䞪ç»èçæ¹æ³ |
CN109070044B (zh) | 2016-07-21 | 2021-07-30 | å®çç©å·¥çšïŒçŸåœ)æéå ¬åž | 䜿çšå€åè£ çœ®è¿è¡çå€zå¹³é¢æåååé |
WO2023158383A2 (en) * | 2022-02-17 | 2023-08-24 | Agency For Science, Technology And Research | Method for cellular lifespan measurement |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02117397A (ja) * | 1988-10-27 | 1990-05-01 | Mitsubishi Heavy Ind Ltd | 埮çç©çŽ°èã®çæ»å€å¥æ³ |
US5321130A (en) * | 1992-02-10 | 1994-06-14 | Molecular Probes, Inc. | Unsymmetrical cyanine dyes with a cationic side chain |
-
1996
- 1996-12-27 EP EP96943322A patent/EP0881489A1/en not_active Withdrawn
- 1996-12-27 US US09/091,128 patent/US20020119438A1/en not_active Abandoned
- 1996-12-27 WO PCT/JP1996/003842 patent/WO1997024616A1/ja active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02117397A (ja) * | 1988-10-27 | 1990-05-01 | Mitsubishi Heavy Ind Ltd | 埮çç©çŽ°èã®çæ»å€å¥æ³ |
US5321130A (en) * | 1992-02-10 | 1994-06-14 | Molecular Probes, Inc. | Unsymmetrical cyanine dyes with a cationic side chain |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4885448B2 (ja) * | 2002-05-03 | 2012-02-29 | ãã©ãã³ ã€ã¡ãŒãžã³ã° ãšãã» ã 㢠| æŸå°æ§å»è¬å補å€ïŒïœïœïœïœïœïœïœïœïœïœïœïœïœ ïœïœïœïœïœïœïœïœïœïœïœïœïœïœïœïœïœïœïŒ |
JP2011503579A (ja) * | 2007-11-09 | 2011-01-27 | ãžã§ã³ã¶ã€ã ã»ã³ãŒãã¬ãŒã·ã§ã³ | å¯Ÿç §çŽ°èã䜿çšããªã现èçåçã®æž¬å®æ¹æ³ |
Also Published As
Publication number | Publication date |
---|---|
US20020119438A1 (en) | 2002-08-29 |
EP0881489A1 (en) | 1998-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1997024616A1 (fr) | Procede de determination du taux de viabilite de cellules | |
US8906697B2 (en) | Method for the assessment of particles and a system and device for use in the method | |
US8097209B2 (en) | Method and apparatus for detecting substances or analytes from the analysis of one or more samples | |
JP5799353B2 (ja) | é µçŽ åºè³ªããã³é µçŽ çæç©ã®åé å·®ã«ããçäœååã®æ€åº | |
US8409850B2 (en) | Microorganism testing device | |
JP2000354483A (ja) | 溶液äžã®æ€äœãåå®ããããã®åæè£ çœ®ããã³ãã®æ¹æ³ | |
WO2014189085A1 (ja) | ã·ãŒã±ã³ãµååŠçè£ çœ®ããã³ãã®æ¹æ³ | |
JP2011092104A (ja) | 埮çç©ãªã©ã®æ€æ»æ¹æ³åã³æ€æ»è£ 眮 | |
Blevins et al. | False-positive cryptococcal antigen latex agglutination caused by disinfectants and soaps | |
JP2006509514A (ja) | 现èãåå®ããããã®æ¹æ³ããã³è£ 眮 | |
JP2008529506A (ja) | 现èåå®æ¹æ³ | |
JPH09329596A (ja) | å°¿äžã®æ圢æååææ¹æ³ããã³è©Šè¬ | |
JPH1099096A (ja) | çå现èæ°ã®æž¬å®æ¹æ³ | |
JPH11319885A (ja) | æ°Žç³»ã«ãããã¢ããªã³æ§é«ååé»è§£è³ªãå«ãåŠçå€æ¿åºŠã®ãªã³ã¹ããªãŒã ç£èŠè£ 眮åã³ãããçšããåŠçå€æ³šå ¥éã®å¶åŸ¡æ¹æ³ | |
EP4339273A1 (en) | Microorganism detection apparatus and microorganism detection method | |
CN107735685B (zh) | äŒ æåšè®Ÿå€ | |
EP1181553A1 (en) | Method and device for counting cells in urine | |
JPH0662897A (ja) | æ žé žè©Šæã®æž¬å®æ¹æ³ããã³æž¬å®è£ 眮 | |
EP0139143B1 (en) | Process and apparatus for measuring the parameters characterizing the microbiological interactions between phages and bacteria | |
Velasco-Arjona et al. | Fully robotic method for characterization of toxic residues | |
WO2023113788A1 (en) | A microfluidic device to dispense a metabolic indicator | |
Gómez-Elvira et al. | Method and apparatus for the detection of substances or analytes from the analysis of one or more samples | |
Viernstein | PROTON TRANSFER EQUILIBRIA | |
JP2003004720A (ja) | æ€äœäžã«å«ãŸããã³ãªã³ãšã¹ãã©ãŒãŒé»å®³ç©è³ªãæ€åºããæ¹æ³åã³ããã«çšãããã¹ãããã | |
JP2006105819A (ja) | ååéçžäºäœçšèšæž¬è£ 眮åã³æ¹æ³ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 09091128 Country of ref document: US |